The Origins and Future of Global Health Law: Regulation, Security, and Pluralism by Halabi, Sam F.
University of Missouri School of Law Scholarship Repository 
Faculty Publications Faculty Scholarship 
5-2020 
The Origins and Future of Global Health Law: Regulation, Security, 
and Pluralism 
Sam F. Halabi 
University of Missouri School of Law, halabis@missouri.edu 
Follow this and additional works at: https://scholarship.law.missouri.edu/facpubs 
 Part of the Health Law and Policy Commons 
Recommended Citation 
Sam F. Halabi, The Origins and Future of Global Health Law: Regulation, Security, and Pluralism, 108 
Georgetown Law Journal 1607 (2020). 
Available at: https://scholarship.law.missouri.edu/facpubs/974 
This Article is brought to you for free and open access by the Faculty Scholarship at University of Missouri School 
of Law Scholarship Repository. It has been accepted for inclusion in Faculty Publications by an authorized 
administrator of University of Missouri School of Law Scholarship Repository. For more information, please contact 
bassettcw@missouri.edu. 
The Origins and Future of Global Health Law:




I. THE ORIGINS OF GLOBAL HEALTH LAW............................ 1613
A. CORPORATIONS, FOOD, AND THE U.N. SECURITY COUNCIL .......... 1616
1. Multinational Corporations........................ 1618
a. Infant and Child Nutrition...................... .1618
b. Tobacco Marketing and Promotion............... 1623
c. Vaccines................................... .1626
2. Private Foundations ............................. 1628
B. FOOD AND AGRICULTURE ................................... 1630
1. The Global Law of Food Safety .................... 1630
2. The Global Law of Animal and Plant Health........... 1632
a. New and Reemerging Pathogens................. 1633
b. Antimicrobial Resistance...................... 1634
C. INTERNATIONAL PEACE AND SECURITY ........................ 1636
II. THE FUTURE OF GLOBAL HEALTH LAW ............................ 1639
A. REGULATING FIRMS AND THEIR PARTNERSHIPS .................. 1639
1. Supranational Regulation ......................... 1639
2. Public-Private Partnerships ....................... 1642
3. The World Trade Organization, ICSID, and Other
Adjudicatory Bodies............................ 1644
* Manley 0. Hudson Professor of Law, the University of Missouri-Columbia; J.D., Harvard Law School;
MPhil, University of Oxfoni (St. Antony's College); B.A., B.S., Kansas State University. 0 2020, Sam F.
Halabi. The author thanks Dayna Bowen Matthew, Maeve McKean, Lawrence 0. Gostin, and participants in
The Georgetown Law Journal Symposium, Law and the Nation's Health, for valuable comments.
1607
THE GEORGETOWN LAW JOURNAL
B. GLOBAL "ONE-HEALTH" LAW............................... 1648
C. GLOBAL HEALTH LAW AS INTERNATIONAL PEACE AND SECURITY LAW 1651
CONCLUSION ...................................................... 1653
INTRODUCTION
The COVID-19 pandemic has presented a global health crisis unlike any seen
in the seventy-five years since the United Nations and the World Health
Organization were formed-"one that is killing people, spreading human suffer-
ing, and upending people's lives. But this is much more than a health crisis. It is a
human crisis. The coronavirus disease (COVID-19) is attacking societies at their
core." It is therefore a crucial point around which to focus the capability of
national and global institutions to address this essential threat o human health
and life. Although the human right to the highest attainable standard of health
was formally established with the adoption of the Constitution of the World
Health Organization (WHO) in 1946 (entering into force in 1948),2 the field of
global health law, oriented to deal with threats like COVID-19, is much younger.3
For many decades, WHO's implementation of its mandate was limited to techni-
cal advice on measures that states (especially developing states) should adopt to
promote individual and public health, as well as a successful campaign com-
mencing in 1967 to address first smallpox and then additional vaccine-prevent-
able diseases in children, which has now expanded even further.4 In the early
2000s, the World Health Assembly (WHA), the governing body of WHO, revised
the International Health Regulations. These revisions gave WHO broader author-
ity to fight disease outbreaks and other public health events of international con-
cem. The WHA also adopted the Framework Convention on Tobacco Control,
1. U.N. SUSTAINABLE DEV. GROUP, SHARED RESPONSIBILITY, GLOBAL SOLIDARITY: RESPONDING TO
THE Socio-ECONOMIC IMPACTS OF COVID-19 (2020), https://unsdg.un.org/sites/default/files/2020-03/
SG-Report-Socio-Economic-Impact-of-Covidl9.pdf [https://perma.cc/95QY-RZB9].
2. Constitution of the World Health Organization, at pmbl., in WHO, Basic Documents 1 (45th ed.
Supp. 2006), http://www.who.int/governance/eb/who_constitution-en.pdf [https://perma.cc/Z9ZT-
5CCV] ("The enjoyment of the highest attainable standard of health is one of the fundamental rights of
every human being without distinction of race, religion, political belief, economic or social condition.").
3. David Fidler and others rightly point out that the history of treaties with at least some "health"
implications dates as far back as 1851, and often dealt with specific diseases, like cholera, or specific
substances, like alcohol or opium. David P. Fidler, The Globalization of Public Health: The First 100
Years of International Health Diplomacy, 79 BULL. WORLD HEALTH ORG. 842, 843-46 (2001). These
treaties, however, centered on the facilitation of trade. See id. at 846 ("The treaties were also not
considered important in connection with public health law generally."). Even international abor law,
much of which dated to the early part of the twentieth century, was focused on managing labor tensions,
not the individual health of workers. See id. at 847 tbl. 5.
4. See WHO, The Immunization Programme That Saved Millions of Lives, 92 BULL. WORLD HEALTH
ORG. 314-15 (2014), https://www.who.int/bulletin/volumes/92/5/14-020514/en/ [https://perma.cc/
5W9K-7LQU] ("In the 1960s, smallpox was still circulating in Africa and Asia. Within a decade of the
launch of the WHO's Intensified Smallpox Eradication Programme in 1967, the disease had been wiped
out globally. Long before the last case of smallpox was reported in 1977, the idea that a similar approach
could be taken with other vaccine-preventable diseases was gaining support.").
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the first use of WHO's Article 19 authority to conclude public health treaties.
COVID- 19 has challenged the sufficiency of even these significant global efforts.
In 2008, Lawrence Gostin and Allyn Taylor defined the field of global health
law.6 According to their analysis, global health law "encompasses the legal
norms, processes, and institutions needed to create the conditions for people
throughout the world to attain the highest possible level of physical and mental
health." Gostin and Taylor fashioned a capacious definition in order to capture
five features of global health law: mission (for example, "basic survival needs"),
key participants, sources, structure, and moral foundations. With Gostin's
Global Health Law in 2014,9 the concept of an international law devoted to the
realization of the highest attainable standard of health worldwide drew broad con-
tours around the subject matter of global health law, including: major threats like
infectious diseases and noncommunicable diseases;0 socioeconomic factors like
global trade, poverty, and government corruption;1 and relevant institutions such
as WHO, the World Bank, the Global Fund, the GAVI Alliance, and the Gates
Foundation.12 In Global Health Law, Gostin scrutinized law most relevant to
global health, the International Health Regulations, and the Framework
Convention on Tobacco Control, but also acknowledged the influence of human
rights law, international trade law, and intellectual property law.13 In significant
measure, the establishment and growth of the field is attributable to these
works.14
5. The stated purpose of the International Health Regulations is "to prevent, protect against, control
and provide a public health response to the international spread of disease in ways that are
commensurate with and restricted to public health risks, and which avoid unnecessary interference with
international traffic and trade." WHO, International Health Regulations 1 (3d ed. 2005), https://apps.
who.int/iris/bitstream/handle/10665/246107/9789241580496-eng.pdf [https://perma.cc/5GYW-PEX3];
see also WHO, WHO Framework Convention on Tobacco Control (2005), https://apps.who.int/iris/
bitstream/handle/10665/42811/9241591013.pdf [https://perma.cc/YM2U-GH64].
6. Lawrence 0. Gostin & Allyn L. Taylor, Global Health Law: A Definition and Grand Challenges, 1
PUB. HEALTH ETHICs 53, 55-56 (2008).
7. Id. at 55.
8. Id.
9. See generally LAWRENCE 0. GOSTIN, GLOBAL HEALTH LAW (2014) (providing the first book-
length, comprehensive survey of the field).
10. See id. at 34-46.
11. See id. at 73-74.
12. See id. at 129-74.
13. See generally id. (covering the IHR, the FCTC, human rights law, international trade and
intellectual property law as they affect the right to health).
14. See Brigit Toebes, International Health Law: An Emerging Field of Public International Law, 55
INDIAN J. INT'L L. 299, 300 n.2, 301 n.10 (2016) (describing Gostin and Taylor's 2008 article as
"comprehensive" and noting Gostin's Global Health Law as "an authoritative study"); Octavio Gomez-
Dants & Julio Frenk, The Quest for Global Justice in Health: A Review of Global Health Law by
Lawrence 0. Gostin, 15 YALE J. HEALTH POL'Y L. & ETHICs 377, 380 (2015) ("Gostin is one of the
pioneers and leading figures in the field of global health law."); Gian Luca Burci, Book Review, 109
Am. J. INT'L L. 691, 691 (2015) ("Research and scholarship on international legal and normative aspects
were initially affected by the very limited scope of international law primarily dedicated to the
protection of health, with the exception of a few pioneering scholars including Gostin [and Taylor].");
St6phanie Dagron, Book Review, EUR. J. INT'L L. 949, 949 (2014) ("Lawrence 0. Gostin's new book
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The purposes of this Article are to revisit and assess the field as it has evolved
since 2014 and to understand the origins of global health law and the forces now
shaping its future with the benefit of new histories and analyses as well as how
those forces are exerted upon the most significant infectious disease threat to face
the world in the last 100 years. This Article undertakes this inquiry in order to
understand how the relevant actors and subjects have changed; whether institu-
tions established since 2000 are still optimally positioned to do the most relevant
work; and whether changes in the relevant subjects of global health law (like ani-
mals and plants) are adequately prioritized. It is the first to undertake such a com-
prehensive review. The Article analyzes those components that Gostin detailed,
like the International Health Regulations, that have become even more important
(and scrutinized) with the COVID-19, Ebola, MERS-CoV, and Zika public health
emergencies. It also identifies those aspects of global health law that have become
ascendant, like the participation of the U.N. Security Council, which in 2014
seemed, only occasionally, concerned with HIV/AIDS, and not with wider health
threats to international peace and security.
While anchored in the human rights discourse typical of post-World War II
regimes, global health law has transitioned from a regime focused on the legal
relationship between sovereign states and between those states and their citizens
to a regulatory force increasingly composed of public-private partnerships." In
addition to its traditional focus on governments, global health law increasingly
regulates corporations and other businesses. As discussed in sections L.A and
II.A, major international treaties and regulatory instruments have become a regu-
lar component of global health law's focus. Historically occupied with measures
taken regarding civilian life during times of peace, global health law is increas-
ingly becoming intertwined with policies aimed at national or international secu-
rity.1 Traditionally focused on human health and medicine, it has now
internalized the interconnectedness of domestic- and wild-animal life, along with
the wider environment that humans and animals share. This has given rise to
"one-health" approaches to the management of animal-, human-, and plant-health
threats." Indeed, the preliminary evidence suggests that COVID-19 spilled over
from bats to humans, either directly or through an intermediary animal host.8
These changes fundamentally challenge the primacy of the historical sources
of global health law (WHO and its Member State governments) and implicate a
begins with the sentence '[t]his is a unique moment to offer a systematic account of global health law'
and he is right.").
15. Toebes, supra note 14, at 301 ("Globalisation only adds a number of new actors to our analysis in
addition to the international society of states, including multinational corporations, non-governmental
organisations and public-private partnerships. As international law is still primarily state-centred, it fails
to call these actors to account directly.").
16. See infra Section I.C (identifying the increasing intervention of the U.N. Security Council on
health-related international emergencies).
17. See, e.g., Paul D. van Helden, Lesley S. van Helden & Eileen G. Hoal, One World, One Health,
14 EMBO REP. 497 (2013).
18. See Kristian G. Andersen et al., The Proximal Origin of SARS-CoV-2, 26 NATURE MED. 450, 450
(2020).
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much larger cast of characters who exercise influence at multiple levels. Global
health law, as it transforms over the course of the twenty-first century and as
health threats like COVID-19 become more frequent and severe, will require
more collaborative lawmaking efforts between U.N. agencies, mediated more of-
ten by the United Nations Security Council.
This transformation will be particularly shaped by mass urbanization and cli-
mate change. Global health law will need to be increasingly informed by the law
of business organizations, including competition or "antitrust" law, as consolida-
tion of large global firms in the agriculture, medical, and pharmaceutical sectors
transform those businesses into actors with state-like reach and influence. Finally,
global health law and international environmental law, especially the law of bio-
diversity conservation, will be shaped by current mechanisms for international
lawmaking like World Trade Organization (WTO) dispute-settlement panels,
international-arbitration fora, and technical, standard-setting processes at intema-
tional organizations like the Organization for Animal Health (OIE), the Codex
Alimentarius Commission (Codex), and the International Organization for
Standardization (ISO). These mechanisms, in turn, will require modification-
the creation of new lawmaking channels-as climate change renders significant
stress on structures developed more than seventy years ago.
These changes offer both threats and opportunities. The increasing "securitiza-
tion" of health law means it may become a primary instrument of abusive and ar-
bitrary state power.19 For example, several states have deployed surreptitious cell
phone technologies to track persons potentially infected with COVID-19 and
their contacts.20 The growing influence of multinational enterprises may compro-
mise access to important innovations and pharmaceuticals because of unafford-
ability.21 The breadth of one-health laws-that is, laws that address health by
looking comprehensively at animal, plant, and human health as well as the envi-
ronments they inhabit-may make global health lawmaking slower and more
complex.
Yet for each of these threats, there are corresponding opportunities for global
health law to "achiev[e] global health ... through legal instruments, legal
19. See Nan D. Hunter, "Public-Private" Health Law: Multiple Directions in Public Health, 10 J.
HEALTH CARE L. & POL'Y 89, 92 (2007) ("Both the proposed new regulations for federal quarantine
authority and a series of emergency planning documents are directed toward the goal of maximizing the
power of government. They evidence little concern for checks against arbitrary uses of that power . . . .");
Ronald Bayer, The Continuing Tensions Between Individual Rights and Public Health, 8 EMBO REP. 1099,
1099 (2007) ("Biggs was but the most articulate of the new cadre of public health officials who endorsed
authoritarian attitudes in the name of public health.. .. ").
20. COVID-19, Surveillance and the Threat to Your Rights, AMNESTY INT'L (Apr. 3, 2020, 10:58
AM), https://www.amnesty.org/en/latest/news/2020/04/covid-19-surveillance-threat-to-your-rights/
[https://perma.cc/3AJP-3SMIN].
21. SAM F. HALAB, INTELLECTUAL PROPERTY AND THE NEW INTERNATIONAL ECONOMIC ORDER:
OLIGOPOLY, REGULATION, AND WEALTH REDISTRIBUTION IN THE GLOBAL KNOWLEDGE ECONOMY 159
(2018) ("To be sure, part of the larger problem was that monopoly rents supported by patents,
trademarks, trade dress, and data exclusivity meant medicines like antiretrovirals, cancer treatments, and
diabetes control drugs would lie out of reach for low- and middle-income countries.").
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capacities, and institutional reforms," in the words of a recent report commis-
sioned by The Lancet and the O'Neill Institute for National and Global Health
Law.2 2 This Article aims to articulate those opportunities and to outline the mech-
anisms by which they may achieve better outcomes for individual and population
health worldwide through the adoption and implementation of global health law.
Although many analysts of global health law have acknowledged the importance
of nonstate actors like businesses,23 none have adequately analyzed the increasing
interlinkages between the U.N. Security Council and global health law, as well as
the growing one-health movement as critical, course-shaping factors for global
health law.
Part I of this Article traces the origins and definitions of "global health law" as
that phrase has changed since the formation of the World Health Organization
and the formal, legal commitment of the world's sovereign states to a human right
to health. Part I challenges the conventional history of global health law, which
tends to emphasize the International Health Regulations and the Framework
Convention on Tobacco Control. It claims that the welfare of infants, children,
and mothers reoriented the post-World War II focus of global health law and
aimed it at multinational enterprises and the importance of food and agriculture;
and that it did so increasingly as a function of international peace and security.
Part II first identifies the emerging and expanding sources of supranational reg-
ulation of global firms, including the regulation of their behavior imposed
through contract or binding agreements and the growth in global health law
formed through adjudication. Part II further analyzes the developing impact of
one-health principles on global health law, and how it is likely to recharacterize
global health law over this century. Finally, Part II ties these trends to the "securi-
tization" of global health law at the U.N. Security Council, including the stale-
mate that has developed between China and the United States over the
characterization of the COVID- 19 threat to international security.
Part III concludes that global health law became increasingly focused on the
protection of infant, child, and maternal health over the course of the 1950s and
1960s, a focus that expanded the diversity and number of subjects it targeted,
especially multinational businesses. As disease threats expanded and became
more severe, global health law also "securitized," such that the U.N. Security
Council and auxiliary, security-oriented organizations became k y sources of
new global health law. As a result, the future of global health law lies in more
supranational regulation of global firms; the influence of agreements between
firms, foundations, and governments (including international organizations); and
22. Lawrence 0. Gostin et al., The Legal Determinants of Health: Harnessing the Power of Law for
Global Health and Sustainable Development, 393 LANCET 1857, 1857 (2019). "Global health" is "an
area for study, research, and practice that places a priority on improving health and achieving equity in
health for all people worldwide." Jeffrey P. Koplan et al., Towards a Common Definition of Global
Health, 373 LANCET 1993, 1995 (2009).
23. See Gostin & Taylor, supra note 6, at 55; Gian Luca Burci, Global Health Law: Present and
Future, in RESEARCH HANDBOOK ON GLOBAL HEALTH LAw 487, 489, 522 n.92 (Gian Luca Burci &
Brigit Toebes eds., 2018).
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the growing body of law generated by adjudicative bodies like international-
investment and trade tribunals. COVID-19, as a dramatic illustration of these
movements, has shown that biomedical interventions are being produced under
the guidance of a bundle of contracts constraining firms that would otherwise
seek to exploit the potential market for a therapeutic or vaccine; the response
being coordinated as a fundamental threat to global security, and that response
has been shaped by stakeholders ranging from regional and national governments
to global financing institutions to global companies. The result of these move-
ments is the future of global health law: regulation, security, and pluralism.
I. THE ORIGINS OF GLOBAL HEALTH LAW
The "enjoyment of the highest attainable standard of health" has been recog-
nized as a "fundamental right[]" since the adoption of the Constitution of WHO
in 1946.24 Abbreviated, somewhat misleadingly, as the "right to health" in much
of the discourse following its establishment, global health law at that time and for
the next two decades was concerned with "the declaration of the right to health as
a basic human right; the prescription of standards aimed at meeting the health
needs of specific groups of persons; and the prescription of ways and means for
implementing the right to health."25
This law was directed at the actions of individual countries. Reflecting on the
field of global health law upon WHO's fortieth anniversary, Professor Michel
B61anger wrote that the "general objective [of international health law] is to sup-
port, guide, and coordinate national health law." 26 Working in partnership with
nongovernmental organizations based in-country, WHO provided technical sup-
port to, hosted meetings for, and thereby contributed significantly to reducing the
incidence of malaria, tuberculosis, poliomyelitis, and other viral diseases around
the world, generally through national-level coordination.27 It also led a number of
maternal-health programs,28 developed nutrition and sanitation guidelines,29 and
worked to ensure appropriate mental-health treatments in member states.30
24. Constitution of the World Health Organization, supra note 2, at pbml.
25. Virginia A. Leary, The Right to Health in International Human Rights Law, 1 HEALTH & HUM.
RTs. 24, 29 (1994) (quoting Theo C. Van Boven, Dir., United Nations Div. of Human Rights, The Right
to Health, Paper for Workshop on the Right to Health as a Human Right (1978), in THE RIGHT TO
HEALTH AS A HUMAN RIGHT: WORKSHOP BY THE HAGUE ACADEMY OF INTERNATIONAL LAW AND THE
UNITED NATIONS UNIVERSITY (Rene-Jean Dupuy, ed. 1979)).
26. Michel B6langer, The Future of International Health Legislation, 40 INT'L DIG. HEALTH LEGIS.
1,2 (1989).
27. See WHO, THE HEALTH OF THE PEOPLE: WHAT WORKS - THE AFRICAN REGIONAL HEALTH
REPORT 58-82 (2014), http://extranet.who.int/iris/restricted/bitstream/handle/10665/137377/978929
0232612.pdf [https://perma.cc/RJ9K-MDKZ].
28. See Maternal Health, WHO, https://www.who.int/maternal-health/en/ [https://perma.cc/W8HS-
EAM6] (last visited Jan. 5, 2020).
29. See, e.g., WHO, ESSENTIAL NUTRITION ACTIONS: IMPROVING MATERNAL, NEWBORN, INFANT
AND YOUNG CHLD HEALTH AND NUTRITION (2013), https://www.who.int/nutrition/publications/
infantfeeding/essential nutrition actions.pdf [https://perma.cc/NB8Y-DDCH].
30. See Mental Health: New QualityRights Modules Launched, WHO (Nov. 29, 2019), https://perma.
cc/Q8BV-ZSET.
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Professor B6langer's statement and the organization's subsequent non-law-
making trajectory would have surprised WHO's founders.3 1 When international
lawmakers established the World Health Organization, they intended to give it
theretofore unheard of, and robust, lawmaking and regulatory authority.32 Article
19 of the WHO Constitution authorized it to adopt treaties relevant to its broad
mandate.33 For example, WHO was authorized to "promote and conduct research
in the field of health by the personnel of the Organization," "establish such other
institutions as it may consider desirable," and "take any other appropriate action
to further the objective of the Organization.' "4
Article 21 gave the World Health Assembly the authority to adopt legally bind-
ing recommendations in five discrete areas: sanitary and quarantine regulations;
nomenclatures on diseases, causes of death, and public health practices; standards
for diagnostic procedures for international use; standards for safety, purity, and
potency of biological, pharmaceutical, and similar products moving in intema-
tional commerce; and advertising and labeling of biological, pharmaceutical, and
similar products moving in international commerce.3 5 Article 22 established the
binding legal effect of these regulations unless tates opted out of them within the
notification period,36 an innovation that limited the delays that accompanied tra-
ditional ratification processes.
One of the first exercises of this authority was in 1951 to adopt the
International Sanitary Regulations, an international agreement that resurrected
and rationalized moribund international treaties that addressed international traf-
fic and quarantine policies oriented at plague, cholera, yellow fever, smallpox,
louse-bome typhus, and relapsing fever.37 WHO updated the regulations and
renamed them in 1969,38 eventually narrowing their reach to yellow fever, chol-
era, and plague by 1981, while expanding the monitoring and control mecha-
nisms applicable to those diseases.3 9 The resurgence of cholera in South
America, plague in India, and Ebola in Africa, as well as the emergence of HIV
as a global pandemic, encouraged the world's countries to consider further, more
31. See V.S. Mihajlov, International Health Law: Current Status and Future Prospects, 40 INT'L
DIG. HEALTH LEGIS. 9, 9 (1989) ("The responses received clearly eflected the general interest shown by
governments, organizations, and individuals in an analysis and study of problems relating to
international medical aw. It is a fact, however, that WHO paid relatively little attention to the matter
thereafter.").
32. See George A. Codding, Jr., Contributions of the World Health Organization and the
International Civil Aviation Organization to the Development of International Law, 59 PROC. AM.
SoC'Y INT'L L. 147, 147-48 (1965).
33. Constitution of the World Health Organization, supra note 2, art. 19.
34. Id. art. 18.
35. Id. art. 21.
36. Id. art. 22.
37. Comment, International Sanitary Regulations, 147 J. AM. MED. Ass'N 62, 62-63 (1951).
38. Strengthening Health Security by Implementing the International Health Regulations (2005): The
International Health Regulations (1969), WHO, https://www.who.int/ihr/current/en/ [https://perma.cc/
CGZ8-QJJ5] (last visited May 18, 2020).
39. Sam F. Halabi, Multipolarity, Intellectual Property, and the Internationalization of Public Health
Law, 35 MICH. J. INT'L L. 715, 723-24 (2014).
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extensive revision.40 WHO was authorized to take action based on information it
collected itself, even if individual countries remained important to the process of
controlling these diseases.4 1
After 1969, the World Health Organization did not exercise its legal powers
for over thirty years.42 Rather, WHO embarked upon several decades of technical
data collection, advice-giving, and support.4 3 WHO "focused on medical and epi-
demiological expertise, coordinating international and non-governmental organi-
zations" (another unique role encouraged by its constitution), "and regular use of
its Article 23 recommendation-issuing authority."44 The World Health Assembly
frequently issued resolutions recommending that governments undertake multi-
ple and diverse measures related to its technical work but avoided lawmaking and
regulation-issuing alternatives available under its constitution.45 According to
David Fidler, this neglect of legal authority was largely attributable to how WHO
historically viewed individual and public health problems.4 6 Because those prob-
lems were medical and scientific, there was little need to do more than dedicate
medical and scientific resources toward their solution.47
This medical-technical ethos did not exhibit interdisciplinary sensibilities
about public health problems because its focus was narrow, static, relatively
inflexible, and largely nonpolitical. International law fell outside this limited
focus because the medical-technical ethos did "not need international law
40. See Frequently Asked Questions About the International Health Regulations (2005), WHO,
https://www.who.int/ihr/about/faq/en/ [https://perma.cc/5Y9Q-JVEZ] (last visited May 18, 2020);
Rebecca Katz & Julie Fischer, The Revised International Health Regulations: A Framework for Global
Pandemic Response, 3 GLOBAL HEALTH GOVERNANCE, 1, 2 (2010).
41. See WHO, International Health Regulations, supra note 5, art. 9, § 1 ("WHO may take into
account reports from sources other than notifications or consultations and shall assess these reports
according to established epidemiological principles and then communicate information on the event to
the State Party in whose territory the event is allegedly occurring. Before taking any action based on
such reports, WHO shall consult with and attempt to obtain verification from the State Party in whose
territory the event is allegedly occurring in accordance with e procedure set forth in Article 10. To this
end, WHO shall make the information received available to the States Parties and only where it is duly
justified may WHO maintain the confidentiality of the source. This information will be used in
accordance with the procedure set forth in Article 11.").
42. See Katz & Fischer, supra note 40, at 2.
43. See David P. Fidler & Lawrence 0. Gostin, The New International Health Regulations: An
Historic Development for International Law and Public Health, 34 J.L. MED. & ETHICs 85, 93 (2006)
("For decades, WHO has issued recommendations on many public health problems; but the mixed
record of state compliance with WHO guidance should temper enthusiasm for the new IHR's
recommendation provisions.").
44. Sam Halabi, Rebecca Katz & Amanda McClelland, International Institutions and Ebola
Response: Learning from the 2017 Outbreak in the Democratic Republic of Congo, 88 ST. Louis U. L.J.
1,4(2019).
45. See David P. Fidler, International Law and Global Public Health, 48 U. KAN. L. REV. 1, 15
(1999) ("WHO operated as if it were not subject to the normal dynamics of the anarchical society;
rather, it acted as if it were at the center of a transnational Hippocratic society made up of physicians,
medical scientists, and public health experts. The nature and dynamics of this transnational Hippocratic
society led WHO to approach international public health without a legal strategy.").
46. See id. at 22-23.
47. Id
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because the approach mandates application of the medical or technical
resource or answer directly at the national or local level."48
A. CORPORATIONS, FOOD, AND THE U.N. SECURITY COUNCIL
Throughout its first two decades, global health law was not effectively law at
all. There were few, if any, firm commitments made by governments, and though
WHO made a large body of general recommendations on a variety of individual
and public health measures, it could only regulate through one weak regulatory
instrument aimed at six diseases (IHR (1969)).
Important exceptions to this assessment were its early effort to eradicate
malaria, and a later, more successful effort to eradicate smallpox. The latter com-
menced in 1961 but failed in the face of inadequate funding and the greater atten-
tion paid to malaria.4 9 By 1967, the vast resources required to eradicate malaria
became clear to the intemational community, and resources were redirected to-
ward smallpox initiatives.0 The smallpox program was an important turning
point in global health law's trajectory. The campaign's success was the result of
legal authorizations for immunization, surveillance, and quarantine first by
African then South Asian governments. The campaign also committed to training
healthcare workers, building laboratories, and creating regular public health
reporting systems." In 1974, the World Health Assembly expanded the smallpox
48. Id. at 23 (citing David P. Fidler, The Future of the World Health Organization: What Role for
International Law?, 31 VAND. J. TRANSNAT'L L. 1079, 1099 (1998)).
49. See Edward A. Belongia & Allison L. Naleway, Smallpox Vaccine: The Good, the Bad, and the
Ugly, 1 CLINICAL MED. & REs. 87, 88 (2003) ("The first large smallpox eradication effort was launched
in 1950 with the goal of eliminating smallpox in the Americas. In 1958, the World Health Assembly
passed a resolution calling for the global eradication of smallpox. Although some countries established
smallpox eradication programs, there was no coordinated infrastructure. Many programs faltered due to
insufficient vaccine supplies and limited resources."); WHO, WHA Res. 14.40, Smallpox Eradication
Programme (1961), https://apps.who.int/iris/bitstream/handle/10665/89023/WHA14.40_eng.pdf [https://
perma.cc/HL9K-FDU5].
50. See D.A. Henderson & Petra Klepac, Lessons from the Eradication of Smallpox: An Interview
with D.A. Henderson, 368 PHIL. TRANSACTIONS ROYAL Soc'Y B 1, 1 (2013) ("During the 1960s,
expenditure for the malaria programme represented 20 per cent or more of all funds available to WHO,
thus constraining other control programmes."); Marcel Tanner & Don de Savigny, Editorial, Malaria
Eradication Back on the Table, 86 BULL. WORLD HEALTH ORG. 82, 82 (2008) ("Regional malaria
elimination campaigns were first conducted in the late 1940s, preparing the ground for the Global
Malaria Eradication Program in 1955. This campaign succeeded in eliminating malaria from Europe,
North America, the Caribbean and parts of Asia and South-Central America. But no major success
occurred in sub-Saharan Africa, which accounts for 80% of today's burden of malaria. When the
aspiration of global eradication was abandoned in 1969, the main reasons for failure were technical
challenges of executing the strategy especially in Africa." (footnotes omitted)).
51. See Henderson & Klepac, supra note 50, at 4 ("Many weak, poorly managed primary healthcare
programmes benefited from the smallpox programme, focusing, as it did, on greatly neglected
vaccination initiatives. To achieve surveillance goals, weekly reports that provided feedback to field
staff demonstrated a national interest in otherwise routine reports and improved morale of many in
isolated primary care units."); Margalit Fox, Dr. J. Donald Millar, 81, Dies; Led C.D.C. Mission That
Helped Eradicate Smallpox, N.Y. TIMES (Sept. 3, 2015), https://www.nytimes.com/2015/09/04/health/
dr-j-donald-millar-who-led-cdc-mission-that-helped-eradicate-smallpox-dies-at-8 1.html (discussing
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program into the Expanded Programme on Immunization (EPI), with the goal of
"reduc[ing] morbidity and mortality by making immunization services available
for all children of the world by 1990.",52 But WHO remained committed to the
study of public health problems and use of evidence-based recommendations and
resolutions, not lawmaking.5 3
Beginning in the mid-1960s, three main influences converged to change the na-
ture and strength of global health law: the increasing influence of multinational
corporations and other large private organizations on all aspects of human-health
systems, the growing impact of agriculture and food systems on individual and
population health, and the growing challenge that transnational health threats
posed to international peace and security. These forces propelled global health
law toward an increasing preoccupation with agriculture and nutrition and caused
it to target corporations as proper subjects of international regulation due to their
health impact. These influences also caused global health law to move to the fore-
front of issues that might require the attention of the most important body over-
seeing international peace and security: the United Nations Security Council.
Section I.A.1 analyzes how WHO's early efforts to eradicate smallpox led to
an increasing focus on infant and child health as the critical points for interven-
tions. With that focus, the practices of large firms that undermined infant and
child health became increasingly urgent matters for national and international
regulatory action. Damaging corporate practices included discouraging exclusive
breastfeeding in the first six months of life; marketing tobacco products to all
populations, but especially children and young adults; and, later, pricing certain
vaccines at high rates. As business practices came into regulatory focus for
infants, children, and mothers, their impact on other health sectors similarly
became more salient.
Section I.B pivots to the global production of food and associated problems in
ensuring its quality and safety. As markets for processed agricultural goods and
packaged foods globalized over the course of the 1960s and 1970s, business prac-
tices related to livestock health, antibiotic use, and land acquisition raised the risk
that novel or reemerging pathogens might infect and spread in humans through
the production or consumption of food. Given the cross-border and trade-related
implications of managing these threats, global health law emerged as an impor-
tant source for regulating food production through international standards and
legal agreements related to animal and plant health.
Section I.C situates these xpansions of global health law into the international
peace and security context. As health threats, often accompanying violent con-
flicts, increased in global significance and risk to human life, global health law
WHO's contribution of people to the smallpox campaign); see generally WHO, The Global Eradication
of Smallpox (1980) (outlining measures taken by WHO during the smallpox eradication programme).
52. Ralph H. Henderson, The Expanded Programme on Immunization of the World Health
Organization, 6 REVS. INFECTIOUs DISEASES S475, S475 (1984).
53. See Fidler, supra note 45, at 15.
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increasingly became a focus of the world's most important security-focused
body: the U.N. Security Council.
1. Multinational Corporations
The influence of multinational firms on individual and public health-as it
came to be conceptualized and prioritized over the course of the 1970s-created
conditions for these firms to be regulated at the supranational evel with far more
specificity than ever before. Firms' activities with respect to children and mothers
became subject to the argument that-because of global reach and corresponding
adverse health outcomes-regulatory mechanisms must correspondingly expand.
a. Infant and Child Nutrition.
The smallpox-eradication effort led directly to the prioritization of interven-
tions to protect infants and children, including growth monitoring, oral rehydra-
tion, promotion of breastfeeding, and immunization, largely focused through
EPI.54 This focus facilitated a shift in global health law toward a greater openness
to the regulation of corporations, both at the national level and through interna-
tional mechanisms.
In 1974, the same year EPI was launched, the World Health Assembly
acknowledged the declining rate of mothers exclusively breastfeeding for the first
six months of life, the period WHO recommends for both maternal and child
health." Because the issue is frequently misunderstood and controversial, it is im-
portant to clarify why WHO recommends exclusive breastfeeding for the first six
months of life. The recommendation is not driven by nutritional variation
between breastmilk and infant formula, but by improper mixing practices preva-
lent in most of the world, often involving contaminated water. Improper mixing,
administration, or nutritional balance results in life-threatening malnutrition and
susceptibility to other diseases.56 "Exclusively breastfed children are less suscep-
tible to diarrhoea and pneumonia and are 14 times more likely to survive than
54. Mariam Claeson & Ronald J. Waldman, The Evolution of Child Health Programmes in
Developing Countries: From Targeting Diseases to Targeting People, 78 BULL. WORLD HEALTH ORG.
1234, 1235 (2000) ("A number of specific, more vertical programmes ... were promoted to channel
relatively meagre resources into areas in which demonstrable success could be achieved in the medium-
term. Furthermore, the emphasis was clearly put on programmes that would contribute to achieving
decreases in mortality among infants and children .... The World Health Organization, for example,
first developed the Expanded Programme on Immunization and subsequently the Programme for the
Control of Diarrheal Diseases. UNICEF chose four specific interventions on which to focus: growth
monitoring, oral rehydration therapy, breast-feeding promotion, and immunization, known by the
acronym GOBI.").
55. See WHO, WHA Res. 27.43, Infant and Young Child Feeding (1974), in WHO, 2 HANDBOOK OF
RESOLUTIONS AND DECISIONS OF THE WORLD HEALTH ASSEMBLY AND THE EXECUTIVE BOARD 58-59
(4th ed. 1981).
56. See Marketing and Promotion of Infant Formula in the Developing Nations, 1978: Hearing
Before the Subcomm. on Health and Sci. Research of the S. Comm. on Human Res., 95th Cong. 1-2
(1978) (statement of Sen. Kennedy).
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non-breastfed children."5 7 Even in wealthier countries, resource-scarce house-
holds have diluted formula in order to make quantities last longer.
Although the declining rates of breastfeeding observed by the World
Health Assembly in 1974 could be somewhat attributed to the inability of
many new mothers in those countries to breastfeed because of their own mal-
nutrition, and some other causes, the evidence strongly suggested that food
firms' aggressive promotion of infant formula, other milk products, cereals
for infants, vegetable mixes, and baby teas and juices "reversed feeding
trends from primarily breastfeeding to formula feeding through pervasive
marketing strategies targeting hospitals, health providers, and the general
public."5 9
During the 1970s and 1980s breastfeeding rates began to rise in the industrial-
ised world, particularly among older, more ducated mothers. Formula compa-
nies responded by vigorously seeking new markets in the developing world.
They gave gifts to health workers and used saleswomen dressed as 'nurses' to
provide donations of formula and advice to mothers. Poverty, illiteracy and
poor sanitation often led to improper formula preparation. Mortality in very
young infants from malnutrition, diarrhoea and pneumonia-virtually
unknown previously-increased ramatically.60
Marketing strategies in poorer countries further asserted that formula was
"modern" and better than breastmilk, depressing breastfeeding rates across the
globe.6 1 In Mexico in 1960, almost 100% of six-month-old babies were breastfed;
by 1966, the number had declined to 40%.62 In Chile, those numbers went from
over 90% of thirteen-month-old babies in 1960 to less than 10% in 1968; in
Singapore in 1951, approximately 80% of three-month-old babies were
57. Nutrition: Improving Breastfeeding, Complementary Foods and Feeding Practices, UNICEF,
https://www.unicef.org/nutrition/index-breastfeeding.html [https://perma.cc/W9RC-XZ5N] (last visited
Feb. 4, 2020).
58. See Stephen Solomon, The Controversy over Infant Formula, N.Y. TIMES (Dec. 6, 1981), https://
www.nytimes.com/1981/12/06/magazine/the-controversy-over-infant-formula.html.
59. See Leif Hambraeus, Proprietary Milk Versus Human Breast Milk in Infant Feeding: A Critical
Appraisalfrom the Nutritional Point of View, 24 PEDIATRIC CLINICIAN OF NORTH AM. 17, 18, 32 (1977);
Derrick B. Jelliffe & E.F. Patrice Jelliffe, Editorial, Feeding Young Infants in Developing Countries:
Comments on the Current Situation and Future Needs, 24 TROPICAL PEDIATRICS & ENVTL. CHLD
HEALTH 155, 155-56 (1978); Ellen G. Piwoz & Sandra L. Huffman, The Impact of Marketing of Breast-
Milk Substitutes on WHO-Recommended Breastfeeding Practices, 36 FOOD & NUTRITION BULL. 373,
379 (2015).
60. June Pauline Brady, Marketing Breast Milk Substitutes: Problems and Perils Throughout the
World, 97 ARCHIVES DISEASE CHLDHOOD 529, 529 (2012) (footnotes omitted).
61. Solomon, supra note 58.
62. F. PHILIP RICE, HUMAN DEVELOPMENT: A LIFE-SPAN APPROACH 140 (3d ed. 1998); see also
ALAN BERG, THE NUTRITION FACTOR: ITS ROLE IN NATIONAL DEVELOPMENT 92, 94 (1973).
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breastfed.63 By 1971, only 5% were.64 Consequently, infant mortality from mal-
nutrition, pneumonia, and diarrhea increased.65
The potential market for infant formula in developing countries was then, and
remains, vast.66 Over the 1970s, the developing-country market was estimated to
run into the billions of dollars.67 Nestl6 accounted for approximately 50% of the
market in that time.68 In 2012, Nestl6 bought Pfizer's baby food division for
$11.9 billion.6 9 Acquiring the Pfizer product line expanded Nestl6's already sub-
stantial reach into developing countries, as 85% of Pfizer's baby-food-division
sales were in developing countries.70 Its marketing investments reflected the im-
portance of developing country markets. In August 1974, for example, Nestl6
broadcasted 135 thirty-second advertisements for its infant formula Lactogen in
Sierra Leone.71
Although its market share is smaller, Abbott's conduct was (and is) similar. In
the Philippines, where only 34% of mothers exclusively breastfeed in the first six
months, Abbott representatives "were described as a constant presence in hospi-
tals." 7 2 There, "they reportedly hand out 'infant nutrition' pamphlets to mothers,
which appear to be medical advice but in fact recommend specific formula brands
and sometimes have money-off coupons."73 In 2018 alone, Abbott Laboratories
spent $790,000 on lobbying "the U.S. Trade Representative, among others, on
'proposals regarding infant nutrition marketing."'74
63. Michael C. Latham, Infant Feeding in National and International Perspective: An Examination
of the Decline in Human Lactation, and the Modern Crisis in Infant and Young Child Feeding Practices,
300 ANNALS N.Y. ACAD. SC. 197, 199 (1977).
64. Id. at 199.
65. See D.B. Jelliffe, Commerciogenic Malnutrition?, 30 NUTRITION REVS. 199, 200-01 (1972).
66. See Kenneth D. Rosenberg et al., Marketing Infant Formula Through Hospitals: The Impact of
Commercial Hospital Discharge Packs on Breastfeeding, 98 AM. J. PUB. HEALTH 290, 294 (2008)
("[F]ormula is now marketed to almost all women.").
67. Pierre A. Borgoltz, Economic and Business Aspects of Infant Formula Promotion: Implications
for Health Professionals, in 2 ADVANCES IN INT'L MATERNAL AND CHILD HEALTH 159 (D.B. Jelliffe &
E.F.P. Jelliffe eds., 1982).
68. Id.
69. Tiffany Hsu, $11.9 Billion for Baby Food? Nestle Pays Up for Pfizer Nutrition, L.A. TIMES (Apr.
23, 2012, 12:00 AM), https://www.latimes.com/business/la-xpm-2012-apr-23-la-fi-mo-nestle-pfizer-
baby-food-20120423-story.html.
70. See id. (identifying Pfizer's baby food division sales in "emerging markets").
71. Russell Mokhiber, Infant Formula: Hawking Disaster in the Third World, 8 MULTINATIONAL
MONITOR para. 8 (1987), https://multinationalmonitor.org/hyper/issues/1987/04/formula.html [https://
perma.cc/M3HF-UKF9].
72. Hannah Ellis-Petersen, How Formula Milk Firms Target Mothers Who Can Least Afford It,
GUARDIAN (Feb. 26, 2018, 7:01 PM), https://www.theguardian.com/lifeandstyle/2018/feb/27/formula-
milk-companies-target-poor-mothers-breastfeeding [https://perma.cc/LX3M-GP4V].
73. Id.
74. Olga Khazan, The Epic Battle Between Breast Milk and Infant-Formula Companies, ATLANTIC
(July 10, 2018), https://www.theatlantic.com/health/archive/2018/07/the-epic-battle-between-breast-
milk-and-infant-fornula-companies/564782/.
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In 1975, a Bristol Myers subsidiary enjoyed a one-year record in profits,
largely because of formula sales.75 It expanded its presence in developing coun-
tries rapidly thereafter.76 By 2008, its Mead Johnson baby-formula business was
valued between $7 billion and $9 billion.77
This growth was accompanied by partnerships, tie-ups, and acquisitions
between market players. Well-known U.S. pharmaceutical companies and food
firms like Gerber78 worked together on marketing and promotional activities,
because there was a strong incentive to increase the overall number of mothers
using breastmilk substitutes.79 "As Mead Johnson's former Chief Executive
Kasper Jakobsen said: 'We have to wait for babies to be born that we can capture.
That can then go through our acquisition, retention, and extension model."'so "By
1980, mothers in developing countries were paying an estimated $1 billion to
Nestl6, Unigate, Bristol Myers, Abbott, Wyeth, Glaxo and other infant formula
companies for products which, in most instances, the mothers did not need."s"
Between 1977 and 1979, the regulation of corporations became part of WHO's
broader strategy in ensuring infant and children's health. Regulating corporations
also shifted the global-health-lawmaking approach from making recommenda-
tions to states to directly regulating nonstate actors through law. This practice
was bidirectional: not only did WHO seek to regulate corporations but also to
negotiate the terms of the regulation with the firms themselves. With the assent of
the WHA, WHO began working with UNICEF on a framework for "regulating
inappropriate sales promotion of infant foods that can be used to replace breast
milk." 8 2 In 1980, the WHA endorsed WHO's and UNICEF's findings and recom-
mended that "there should be an international code of marketing of infant formula
75. Ann Crittenden, Baby Formula Sales in Third World Criticized, N.Y. TIMES (Sept. 11, 1975),
https://www.nytimes.com/1975/09/1 1 archives/baby-formula-sales-in-third-world-criticized-some-
producers-accused.html.
76. See Marketing and Promotion of Infant Formula in the Developing Nations, 1978, supra note 56,
app. at 224-25 (supplementary testimony of James E. Post, Sch. of Mgmt., Bos. Univ.).
77. Lina Saigol & Christopher Bowe, Bristol-Myers Sounds Out Baby Food Sale, FIN. TIMES (Mar.
16, 2008), https://www.ft.com/content/e6356bb0-f387-1 ldc-b6bc-0000779fd2ac.
78. Gerber was acquired by Sandoz in 1994 and later by Novartis. See Associated Press, Nestl to
Buy Gerber for $5.5 Billion, N.Y. TIMES (Apr. 13, 2007), https://www.nytimes.com/2007/04/13/
business/13gerber.html. In 2007, its baby food unit was then sold to Nestle. Id.
79. See Heather Clancy, Gerber to Introduce Baby Formula in Deal with Bristol-Myers, UNITED
PRESS INT'L (June 15, 1989), https://www.upi.com/Archives/1989/06/15/Gerber-to-introduce-baby-
formula-in-deal-with-Bristol-Myers/2260613886400/ [https://perma.cc/G3UB-HJKS].
80. SAVE THE CHLDREN, DON'T PUSH IT: WHY THE FORMULA MILK INDUSTRY MUST CLEAN UP ITS
ACT, at vi (2018), https://www.savethechildren.org.uk/content/dam/gb/reports/health/dont-push-it.pdf
[https://perma.cc/KB9W-6QJZ].
81. Mokhiber, supra note 71, ¶ 14.
82. WHO, INTERNATIONAL CODE OF MARKETING OF BREAST-MILK SUBSTITUTES 4 (1981) (quoting
WHO, WHA Res. 31.47 (1978)), in WHO, 2 HANDBOOK OF RESOLUTIONS AND DECISIONS OF THE
WORLD HEALTH ASSEMBLY AND THE EXECUTIVE BOARD 62 (4th ed. 1981), https://www.who.int/
nutrition/publications/code-english.pdf [https://perma.cc/5LD5-GAYB].
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and other products used as breast-milk substitutes."83 In early 1981, WHO
endorsed a draft of the International Code on the Marketing of Breast-milk
Substitutes (International Code) and recommended it to the WHA, which adopted
it by an overwhelming vote.84
The extensive involvement of all major actors in negotiations contributed to
the development of detailed, meaningful regulations. WHO and UNICEF
ensured the participation and consultation of all interested parties while limit-
ing the actual drafting to the secretariats....
The final negotiations between Nestl6 and the INBC [(the International Nestl6
Boycott Committee)] were carried out at UNICEF in New York... .
UNICEF's role as a facilitator of the negotiations and the final agreement
between Nestl6 and its critics was also a departure from the customary
activities of international organizations.
The final joint agreement between Nestl6 and the INBC guarantees that the
corporation will abide by a voluntary code of conduct worked out in an inter-
national organization."
As a result of these efforts, the International Code in many countries now pre-
vents companies from advertising, subject o constitutional limitations; imple-
ments strict labeling requirements, including a proscription on infant images or
other pictures that idealize breastmilk substitutes; limits influence on healthcare
workers; and prohibits distribution of free samples of breast milk substitutes.86
The International Code, together with subsequent recommendations, represents
an evidence-based minimum standard that informs human-rights obligations for
both states and companies.8 7
As of March 2016, 135 countries had at least some form of legal measure in
place covering some provisions of the Code. This represents significant pro-
gress since 2011, when only 103 countries had relevant legal measures in
place. A total of 39 countries have comprehensive legislation or other legal
measures reflecting all or most provisions of the Code. An additional 31 coun-
tries have legal measures incorporating many provisions of the Code, and a
further 65 countries have legal measures that contain a few provisions. 49
83. Id. at 5 (quoting WHO, WHA Res. 33.32, Infant and Young Child Feeding (1980), in id. at annex
2).
84. Id. at 5 & n.7.
85. Kathryn Sikkink, Codes of Conduct for Transnational Corporations: The Case of the WHO!
UNICEF Code, 40 INT'L ORG. 815, 833 (1986).
86. Id. at 822.
87. See U.N. Convention on the Rights of the Child, General Comment No. 15 on the Right of the
Child to the Highest Attainable Standard of Health, art. 24, ¶ 2(e) (Apr. 17, 2013); Sami Shubber, The
International Code of Marketing of Breast-Milk Substitutes, 36 INT'L DIG. HEALTH LEGIS. 877, 884-85
(1985).
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countries have non-legal or no measures in place. No information was avail-
able for 10 countries.8
b. Tobacco Marketing and Promotion.
Although it is far more lethal and far more tied to the activity of multinational
corporations, tobacco did not become a major focus of global health law until af-
ter litigation in the United States exposed the breadth and depth of industry prac-
tices aimed at marketing, promotion, and deception.8 9 Tobacco consumption
annually kills approximately 8 million people around the world and represents
the principal preventable threat to individual and public health worldwide.90
Though consumption of tobacco products, especially combustible types like ciga-
rettes, causes various cancers, cardiovascular disease, and chronic obstructive
pulmonary disease, second-hand smoke increases risks for disease in non-smok-
ers as well.91
"Between 1970 and 1998, the [WHA] ... had adopted 17 resolutions on differ-
ent aspects of tobacco control."92 In its first major assessment of the evidence on
the relationship between smoking and health, WHO acknowledged the "useful
role of legislation" in addressing the threat but hardly mentioned the role of inter-
national tobacco companies as targets of regulation or as causes of the problem.93
By 1979, WHO had reached a far firmer conclusion on the role of tobacco
companies:
It must be recognized that the tobacco industry has presented, and will con-
tinue to present, a formidable barrier to smoking control. .. . [N]o worthwhile
progress can be achieved unless governments are prepared to put the interests
of public health before those of private tobacco enterprise . . . . The interna-
tional tobacco industry's irresponsible behaviour and its massive advertising
and promotional campaigns are ... direct causes of a substantial number of
unnecessary deaths. The Committee expressed particular concern at the
tobacco industry's expansionary approach to the developing countries.4
88. WHO, UNICEF & IBFAN, MARKETING OF BREAST-MILK SUBSTITUTES: NATIONAL
IMPLEMENTATION OF THE INTERNATIONAL CODE STATUS REPORT 2016, at 1 (2016).
89. See Sam Foster Halabi, The World Health Organization's Framework Convention on Tobacco
Control: An Analysis of Guidelines Adopted by the Conference of the Parties, 39 GA. J. INT'L & COMP.
L. 121, 129-30 (2010).
90. See Tobacco, WHO (July 26, 2019), https://www.who.int/news-room/fact-sheets/detail/tobacco
[https://perma.cc/PD5G-GDSX].
91. See id.; Gro Harlem Brundtland, Dir.-Gen., Burden of Disease and Best Practices: High-Level
Roundtable on Tobacco Control and Development Policy, WHO (Feb. 3, 2003), http://www.who.int/dg/
speeches/2003/brussels/en/ [https://perma.cc/7837-E8EC].
92. Heather Wipfli & Jonathan M. Samet, One Hundred Years in the Making: The Global Tobacco
Epidemic, 37 ANN. REV. PUB. HEALTH 149, 155 (2016).
93. EXPERT COMM., WHO, SMOKING AND ITS EFFECTS ON HEALTH, TECHNICAL REPORT No. 568, at
25 (1975), https://apps.who.int/iris/bitstream/handle/10665/41157/WHO_TRS_568_eng.pdf [https://
perma.cc/6YCC-V9SJ].
94. EXPERT COMM. ON SMOKING CONTROL, WHO, CONTROLLING THE SMOKING EPIDEMIC, TECHNICAL
REPORT No. 636, at 8-9 (1979), https://apps.who.int/iris/bitstream/handle/10665/41351/WHO TRS_636.
pdf [https://perma.cc/XX7Z-3ZWF].
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Not until 1980 did those resolutions identify the role of tobacco companies in
perpetuating a public health epidemic.95
WHO and large tobacco companies became more antagonistic over the course
of the 1980s and 1990s-indeed, WHO compiled an entire report on industry
efforts to undermine the tobacco industry's work.96 But it was not until litigation
in the United States uncovered the extent of companies' tactics worldwide that
WHO determined that a regulatory instrument at the international level was
needed.97 The release of correspondence between parent companies and
foreign subsidiaries as part of the Master Settlement Agreement in U.S. liti-
gation opened a window into the operations of transnational tobacco compa-
nies.98 "Accordingly, tobacco control advocates, researchers, and litigants
working outside the United States have made extensive use of the documents
to support their own health policy efforts." 99
Because multinational tobacco corporations represented a critical barrier to
the adoption of tobacco-control regulation, Canada, Finland, Mexico, and
Tanzania sponsored the idea of an international agreementoo to regulate tobacco
95. See WHO, WHA33.35 WHO's Programme on Smoking and Health (1980), https://www.who.int/
tobacco/framework/wha eb/wha33_35/en/ [https://perma.cc/9CSC-VJTD].
96. See generally COMM. OF EXPERTS ON TOBACCO INDUS. DOCUMENTS, WHO, TOBACCO COMPANY
STRATEGIES TO UNDERMINE TOBACCO CONTROL ACTIVITIES AT THE WORLD HEALTH ORGANIZATION
(2000), https://www.who.int/tobacco/en/whojinquiry.pdf [https://perma.cc/6D85-TMBP] (reviewing
strategies deployed by tobacco companies to discredit WHO and derail efforts at forming a tobacco
control treaty).
97. Id. at 242; Derek Yach, The Origins, Development, Effects, and Future of the WHO Framework
Convention on Tobacco Control: A Personal Perspective, 383 LANCET 1771, 1771 (2014) ("In May
1998, the WHO noted the document and a related resolution in words that would support he WHO
FCTC: 'as global interdependence increases, so will the need for global, ethical, and scientific norms,
standards and commitments, including some that are legally binding."').
98. See Jeff Collin, Kelley Lee & Karen Bissell, The Framework Convention on Tobacco
Control: The Politics of Global Health Governance, 23 THIRD WORLD Q. 265, 267 (2002); Ruth
Roemer et al., Origins of the WHO Framework Convention on Tobacco Control, 95 AM. J. PUB.
HEALTH 936, 938 & nn.8-9 (2005); An International Tobacco Control Policy: Policy Number 9809,
AM. PUB. HEALTH Ass'N (1998), https://www.apha.org/policies-and-advocacy/public-health-policy-
statements/policy-database/2014/08/29/11/06/an-international-tobacco-control-policy.
99. Richard D. Hurt et al., Open Doorway to Truth: Legacy of the Minnesota Tobacco Trial, 84
MAYO CLINIC PROC. 446,451 (2009).
100. Hiroshi Nakajima, Dir.-Gen., WHO, The Feasibility of Developing an International Instrument
for Tobacco Control, EB97/INF.DOC./4 (Nov. 30, 1995); Collin, Lee & Bissell, supra note 98, at 266
(finding a transnational approach to be necessary because the tobacco industry benefitted from
globalization through "facilitated access to markets worldwide by the tobacco industry through trade
liberalisation and specific provisions under multilateral trade agreements; enhanced marketing,
advertising and sponsorship opportunities via global communication systems; greater economies of
scale ranging from the purchase of local cigarette manufacturers, improved access to ever larger markets
and the development and production of global brands; and the ability of transnational corporations
(TNCs) to undermine the regulatory authority of national governments"); Yach, supra note 97, at 1771
("Transnational tobacco control gained support as countries with effective policies recognised their
progress could be undermined by cross-border advertising and illicit trade, resulting in an unintended
consequence: the rapid expansion of tobacco use in resource-poor countries."); Roemer et al., supra note
98, at 937.
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companies at the WHA in 1995."o0 In 1998, Member States of the World Health
Organization established a Working Group to draft provisions of a treaty-the
first in WHO's history-to address the major supply-and-demand factors contrib-
uting to tobacco consumption.10 2 The Framework Convention on Tobacco
Control (FCTC) was adopted by the WHA in 2003 and entered into force on
February 27, 2005.103 One hundred and eighty-one parties have ratified or
acceded to the FCTC, with the most recent to do so in July 2017. 104
Whereas large multinational corporations negotiated directly with WHO on
aspects of the International Code of Marketing of Breast-milk Substitutes, the
nature of industry interference in tobacco control and its essential interest in
undermining public health caused WHO to determine that tobacco firms should
not participate in the FCTC drafting process."o' When the Conference of the
Parties, the governing body of the FCTC, convened in 2008 to elaborate guide-
lines for implementation, it declared, pursuant to Article 5.3 of the treaty, that
there was a "fundamental and irreconcilable conflict" between the treaty and the
tobacco industry.106 Though the FCTC regulates a wide range of supply-and-
demand factors affecting tobacco consumption, core aspects of its nonprice provi-
sions are aimed at eliminating or limiting business practices crucial to tobacco
firms. Article 11 (packaging and labeling) and Article 13 (promotion) limit firms'
ability to use advertisement and color schemes to deceive consumers.10 7 The
101. WHO, WHA48.11: An International Strategy for Tobacco Control (May 12, 1995), http://www.
who.int/tobacco/framework/wha eb/wha48_11/en [https://perma.cc/AXD8-26P8].
102. See Working Group Preceding the Intergovernmental Negotiating Body on the WHO FCTC
(1999-2000), FCTC: WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL, https://www.who.int/
fctc/about/pre-neg-working-group/en/ [https://perma.cc/2TVZ-EHE5] (last visited Jan. 6, 2020);
WHO, WHO Framework Convention on Tobacco Control, supra note 5, at v.
103. WHO, WHO Framework Convention on Tobacco Control, supra note 5, at vi, 35.
104. Parties to the WHO Framework Convention on Tobacco Control, WHO (Nov. 23, 2017), http://
www.who.int/fctc/signatoriesparties/en/index.html [https://perma.cc/AT28-DHGY].
105. See Collin, Lee & Bissell, supra note 98, at 267, 276, 279; Yach, supra note 97, at 1772 ("An
inquiry initiated by WHO in collaboration with the World Bank led to a report showing well-financed
and effective industry efforts to stop, slow, or delay the introduction of effective tobacco control policies
within WHO and member states. The inquiry yielded outcomes in two areas without which there might
have been no WHO FCTC. The World Health Assembly adopted Transparency in tobacco control, a
2001 resolution warning governments about tobacco industry actics, and developed language
supportive of making tobacco companies liable for harm in the final adopted text of the WHO FCTC. It
also galvanised a global network of nongovernmental organisations linked to major media, which
reframed the tobacco control debate in terms of corporate accountability rather than human frailty.
Public access to industry records also led to the discovery that some critics of tobacco control were on
the industry payroll-notably Roger Scruton, whose opinion pieces appeared in The Wall Street Journal
and Financial Times. In a lengthy email exchange, he quibbled with his Japan Tobacco International
paymasters about his fees for editorials and commentaries related to tobacco." (footnotes omitted));
Gregory F. Jacob, Without Reservation, 5 CHI. J. INT'L L. 287, 297 (2004) ("The NGOs complained
vociferously about a supposed tobacco industry lobbying campaign aimed at sinking the Convention,
but other than a couple of representatives of the duty-free lobby, the tobacco industry was nowhere to be
found.").
106. WHO, Guidelines for Implementation of Article 5.3 of the WHO Framework Convention on
Tobacco Control 2 (Nov. 2008), https://www.who.int/fctc/guidelines/article_5_3.pdf [https://perma.cc/
M76J-DMHT].
107. WHO, WHO Framework Convention on Tobacco Control, supra note 5, arts. 11, 13.
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Conference of the Parties has issued additional guidelines that go further in limit-
ing tobacco business practices and keeping those firms away from public health
policymaking.0 8
c. Vaccines.
As with legal challenges to the marketing of infant foods and tobacco, the
introduction of vaccines was one of the principal interventions that elevated the
health of children in not only the developing but also the wealthy world.109
Vaccines are not only critical for the prevention of illnesses in children but are
one of the most important lines of defense against the emergence of pandemics.10
Indeed, giving researchers as much time as possible to develop a vaccine is one
of the principal justifications for the significant social distancing and lockdown
measures now imposed by governments in response to COVID-19. 111
Although many vaccines distributed through the Expanded Programme on
Immunization were not patented, later vaccines, especially influenza vaccines,
were.112 Seasonal and pandemic influenza vaccines are possible in significant part
because developing countries share influenza samples with the WHO's Global
Influenza Surveillance and Response System (GISRS).113 Access to viruses is
crucial to the development of vaccines and other treatments. WHO's system
allows countries to effectively coordinate surveillance efforts for influenza out-
breaks.114 Through the GISRS, national influenza centers submit local virus sam-
ples to WHO for monitoring and research.15
As was the case with infant foods and tobacco, multinational corporations'
involvement with vaccines created barriers to, rather than facilitated, improved
108. See Halabi, supra note 89, at 125.
109. See Christopher Ingraham, In 2013, Measles Killed More Kids than Car Accidents or AIDS,
WASH. PosT (Feb. 25, 2015), www.washingtonpost.com/blogs/wonkblog/wp/2015/02/25/in-2013-
measles-killed-more-kids-than-car-accidents-or-aids/.
110. See Seth Berkley, Global Vaccine Access as a Critical Intervention to Fight Infectious Disease,
Antibiotic Resistance, and Poverty, in GLOBAL MANAGEMENT OF INFECTIOUS DISEASE AFTER EBOLA
179, 179 (Sam Halabi, Lawrence Gostin & Jeff Crowley eds., 2017); Eileen M. Kane, Achieving
Clinical Equality in an Influenza Pandemic: Patent Realities, 39 SETON HALL L. REV. 1137, 1145
(2009).
111. Joe Pinsker, The Four Possible Timelines for Life Returning to Normal, ATLANTIC (Mar. 30,
2020, 4:40 PM), https://www.theatlantic.com/family/archive/2020/03/coronavirus-social-distancing-
over-back-to-normal/608752/.
112. See Kane, supra note 110, at 1158.
113. Kumanan Wilson, Barbara von Tigerstrom & Christopher McDougall, Protecting Global
Health Security Through the International Health Regulations: Requirements and Challenges, 179
CANADIAN MED. Ass'N J. 44, 46 (2008); see also Fidler & Gostin, supra note 43, at 90 (describing the
IHR requirement hat WHO share information relating to public health risks with all states).
114. See Sam Halabi, Viral Sovereignty, Intellectual Property, and the Changing Global System for
Sharing Human Pathogens for Infectious Disease Research, 28 ANNALS HEALTH L. & SCI. 101, 109-10
(2019).
115. Marie Wilke, The World Health Organization's Pandemic Influenza Preparedness Framework
as a Public Health Resources Pool, in COMMON POOLS OF GENETIC RESOURCES: EQUITY AND
INNOVATION IN INTERNATIONAL BIODIVERSITY LAw 315, 316-17 (Evanson Chege Kamau & Gerd
Winter eds., 2013).
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health outcomes. The infrastructure and technology for vaccine development
is overwhelmingly located in a small number of firms based in wealthy
states.11 6 Five large firms generate approximately 80% of global vaccine sales
across all products.1 1 7 Many of the markets for individual vaccine products
operate as monopolies or oligopolies.1 s This concentration renders many
developing states dependent on wealthier states to manufacture and distribute
vaccines in sufficient quantities to address their needs in routine and emer-
gency circumstances.119 These states must therefore be willing to share dis-
ease samples and biological material relevant to risk assessment, risk
management, disease research, and vaccine development. When firms patent
shared samples to produce unaffordable vaccines, the willingness to share is
undermined. 120
In 2006, Indonesia withheld H5NT avian-flu samples from the WHO sys-
tem, compromising efforts to monitor and produce vaccines in response to an
avian-flu outbreak that had not only spread worldwide but hreatened to
become easily transmissible from birds to humans and then between
humans.12 1 Indonesia asserted that its decision was a response to an Australian
company's development of a vaccine derived from a virus sample Indonesia
provided to WHO.12 2 The cycle demonstrated the inequities inherent in the
global vaccine-distribution system: "Developing countries provided informa-
tion and virus samples to the WHO-operated system; pharmaceutical compa-
nies in industrialized countries then obtained free access to such samples,
exploited them, and patented the resulting products, which the developing
countries could not afford." 1 23
"The resolution to Indonesia's complaints about [GISRS] was the 2011
Pandemic Influenza Preparedness Framework (PIP Framework)."124 WHO nego-
tiated the PIP Framework, and the World Health Assembly passed it as an Article
116. Sam F. Halabi & John Monahan, Regulatory Capacity in Low- and Middle-Income Countries:
Lessons from the HIN1 Influenza Pandemic, in FOOD AND DRUG REGULATION IN AN ERA OF
GLOBALIZED MARKETS 63, 65, 66 fig.6.1 (Sam F. Halabi ed., 2015).
117. Immunization, Vaccines, and Biologicals: Vaccine Market, WHO, http://www.who.int/
immunization/programmes-systems/procurement/market/global-supply/en/ [https://perma.cc/N2FK-
YEF5] (last visited Jan. 6, 2020).
118. Id.
119. See, e.g., David P. Fidler, Negotiating Equitable Access to Influenza Vaccines: Global Health
Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza HIN1, 7
PLoS MED., May 2010, at 1-2.
120. See id.
121. David P. Fidler, Influenza Virus Samples, International Law, and Global Health Diplomacy, 14
EMERGING INFECTIOUS DISEASES 88, 88 (2008).
122. Id.
123. Id.
124. Sam Halabi & Rebecca Katz, Introduction, in VIRAL SOVEREIGNTY AND TECHNOLOGY
TRANSFER, AND THE CHANGING GLOBAL SYSTEM FOR SHARING HUMAN PATHOGENS FOR INFECTIOUS
DISEASE RESEARCH 49 (Sam Halabi & Rebecca Katz eds., forthcoming 2020) (manuscript at 49).
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23 resolution in May 2011.125 The PIP Framework was committed to "increas[ing]
the access of developing countries to vaccines and other pandemic related sup-
plies." 126 Under the PIP Framework, firms retain their ability to access samples
shared through GISRS, but now they must contribute towards half the cost of its
maintenance.127 Firms must also promise to share either intellectual property, prod-
ucts developed through use of the system, or other medical countermeasures critical
to pandemic response.128
The International Code, the FCTC, and the PIP Framework facilitated what is
now a fundamental shift in the course of global health law: direct relationships
between lawmaking processes and corporations, not only through their national gov-
ernments.129 Moreover, the direct relationship between firms and international regu-
latory instruments has been channeled to international dispute resolution fora like
the WTO Dispute Settlement Understanding, ICSID arbitral tribunals, and national
courts.130 It has also been directed toward major standard-setting organizations like
Codex (described in section I.B. 1) and the Organization for Animal Health (OIE),
where health standards must meet both consumer-protection and trade-liberalizing
objectives.131 The future of global health law is therefore at the intersection of inter-
national-regulatory bodies and international-dispute-settlement bodies, as much as
or more than it is at international health organizations like WHO.
2. Private Foundations
Not only for-profit entities have reached the size and influence of states or
international organizations. Prominent nongovernmental organizations like the
Bill and Melinda Gates Foundation; the Bill, Hillary and Chelsea Clinton
Foundation; and the Bloomberg Family Foundation have prioritized individual
and public health initiatives, earned seats at important decisionmaking tables, and
regulated through contract the behavior of firms, governments, and international
125. WHO, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines
and Other Benefits, WHA 64.5 (May 24, 2011), in PANDEMIC INFLUENZA PREPAREDNESS FRAMEWORK:
FOR THE SHARING OF INFLUENZA VIRUSES AND ACCESS TO VACCINES AND OTHER BENEFITS 1 (2011)
[hereinafter WHO, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to
Vaccines and Other Benefits], https://apps.who.int/iris/bitstream/handle/10665/44796/9789241503082_
eng.pdf [https://perma.cc/FQ4U-7BUG].
126. Pandemic Influenza Preparedness (PIP) Framework, WHO, http://www.who.int/influenza/pip/
en/ [https://perma.cc/ZF7Q-9RR2] (last visited Jan. 6, 2020).
127. See Lawrence 0. Gostin et al., Virus Sharing, Genetic Sequencing, and Global Health
Security, 345 SCIENCE 1295, 1296 (2014); WHO, PANDEMIC INFLUENZA PREPAREDNESS FRAMEWORK:
DISTRIBUTION OF PARTNERSHIP CONTRIBUTION AMONG COMPANIES 1 (2013), https://www.who.int/
influenza/pip/pc-distribution.pdf [https://perma.cc/D9MV-BG46].
128. See WHO, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to
Vaccines and Other Benefits, supra note 125, at 33-35 art. 4.1.1.
129. See HALABI, supra note 21, at 217-26.
130. Id. at 76.
131. See Sam F. Halabi & Ching-Fu Lin, Assessing the Relative Influence and Efficacy of Public and
Private Food Safety Regulation Regimes: Comparing Codex and GlobalG.A.P. Standards, 72 FOOD &
DRUG L.J. 262, 282-83 & n.164 (2017).
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organizations.13 2 For example, in a renewed effort to complete the work begun
with the WHO's Expanded Programme on Immunization, the Bill and Melinda
Gates Foundation together with WHO, UNICEF, the World Bank and several
large pharmaceutical firms established the Global Alliance for Vaccines and
Immunizations (GAVI). 13 3 GAVI is funded through the International Finance
Facility for Immunisation (IFFIm), which is itself funded by the governments of
Australia, Brazil, France, Italy, the Netherlands, Norway, South Africa, Spain,
Sweden, and the United Kingdom.1 34
Under the GAVI model, low- and middle-income states identify immunization
needs, apply for funding, and implement approved vaccination programs.135
Under GAVI's program, donors guarantee the price of eligible vaccines.136
Pharmaceutical firms, in turn, guarantee the vaccines at an affordable price to par-
ticipating countries.137 The relationships in GAVI are governed by contract.
Through these contracts and the surrounding negotiations and relationships, foun-
dations can exercise significant influence on the firms that participate.1 38
The creation of Gavi ... facilitated the use of breakthrough technologies to
expand access to new vaccines, as well as traditional immunizations that may
have been delayed for decades without Gavi support. For example, between
Gavi's inception and 2014, DTP3 coverage in Gavi-supported countries rose
from 60% to 81%. This change had a direct impact on disease burden: between
1980 and 2014, cases of diphtheria declined by 92%, pertussis by 91%, and tet-
anus by 90%.139
GAVI is just one example of a public-private partnership, which in the global
health space number in the hundreds.140 The participation of nongovernmental
organizations in global public health lawmaking will continue to shape the
132. See Lisa Clarke, Responsibility of International Organizations Under International Law for the
Acts of Global Health Public-Private Partnerships, 12 CHI. J. INT'L L. 55, 59-60 (2011).
133. History of GAVI, GAVI, https://perma.cc/2ZTP-YFK4 (last visited Jan. 7, 2020).
134. Overview, IFFIM, https://perma.cc/4GJM-C4GL (last visited Mar. 18, 2020).
135. See GAVI, How WE WORK TOGETHER 14 (2019), https://www.gavi.org/sites/default/files/
document/2019/How%20we%20work%20together.pdf [https://perma.cc/Y7GY-3952] (last visited Mar.
18, 2020).
136. See id. at 6.
137. See Ilona Kickbush, Wolfgang Hein & Gaudenz Silberschmidt, Addressing Global Health
Governance Challenges Through a New Mechanism: The Proposal for a Committee C of the World
Health Assembly, 38 J.L. MED. & ETHICs 550, 554 (2010) ("The parallels to the dominant position of the
Bill & Melinda Gates Foundation today-who in 2007 spent roughly as much on global health as
WHO's budget for that year-are obvious.... They now have a significant impact on setting agendas,
shaping global health policies and implementing programs.").
138. See id. Also relevant is the Global Fund's regulation of "suppliers," "including bidders,
suppliers, agents, intermediaries, consultants and contractors and representatives of each of the above."
Sanctions Panel Procedures Relating to the Code of Conduct for Suppliers, GLOBAL FUND 1 (June 19,
2015), https://www.theglobalfund.org/media/6015/corporate-sanctionsprocedures-policy-en.pdf [https://
perma.cc/99SM-2MVINE].
139. Berkley, supra note 110, at 181 (footnote omitted).
140. Kickbush, Hein & Silberschmidt, supra note 137, at 554.
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direction of global health law as contracts between firms, governments, and inter-
national organizations internalize regulatory norms.141
B. FOOD AND AGRICULTURE
For the most part, concerns with food and agriculture after World War II
focused on food shortages, growing populations, and regular famine.142 in
response, scientists from India, Mexico, the Philippines, and the United States
partnered with international organizations and foundations to create a system of
cross-country research experiments focused on producing high-yield varieties of
cereal grains to feed more people.143 This scientific collaboration created a system
that could sustain further research in poorer countries in the future. Alongside the
research collaborations, wealthier countries committed to transferring technolo-
gies like tractors, fertilizers, and pesticides for higher-yield crops to continue.1
Farmers were able to adopt the new high-yield varieties quickly, and food pro-
duction was able to keep up with local population growth.145 Known as the
"Green Revolution," the production of high-yield grains, establishment of
research centers in poorer countries, and technology transfer boosted average ca-
loric intake in emerging regions as food prices declined, leading to better health
outcomes and longer lives.146 The Green Revolution also ushered in the global
mechanization and industrialization of food production, with effects for global
health law detailed below.
1. The Global Law of Food Safety
As mechanization supported increased global trade in food throughout the
1950s, food additives in processed fruits, vegetables, and milk became significant
areas of concern for individual and public health.14 7 Between 1971 and 2001, the
growth in food imports was especially notable in low- and middle-income coun-
tries, which saw a rise of 115%, compared to wealthier countries at 45%. 148 Food
imports into all countries are increasingly processed; from 1991 to 2000, trade in
processed food products accounted for some 66% of agricultural trade.149 Along
with imports come risks for spoilage, adulteration, and contamination. "An esti-
mated 600 million-almost 1 in 10 people in the world-fall ill after eating
141. See, e.g., Sam F. Halabi, Michelle Rourke & Rebecca M. Katz, The Law and Ethics of Data
Sharing During Infectious Disease Emergencies, 8 J. HEALTHCARE L. & POL'Y (forthcoming 2020)
(manuscript at 4-5) (identifying instances where large foundations swayed large pharmaceutical firms
during the Ebola emergency through the use of their data sharing agreements).
142. See W.B. Dickinson Jr., World Food Shortages, 2 EDITORIAL RES. REP. 1-2 (1965).
143. See Derek Byerlee & Harvey Jesse Dubin, Crop Improvement in the CGIAR as a Global
Success Story of Open Access and International Collaboration, 4 INT'L J. COMMONS 452, 456 (2010).
144. See id.
145. See id.
146. R. E. Evenson & D. Gollin, Assessing the Impact of the Green Revolution, 1960 to 2000, 300
SCIENCE 758, 758, 761 (2003).
147. See Sam F. Halabi, The Codex Alimentarius Commission, Corporate Influence, and
International Trade: A Perspective on FDA's Global Role, 41 AM. J.L. & MED. 406, 408 (2015).
148. FOOD & AGRIC. ORG., THE STATE OF AGRICULTURAL COMMODITY MARKETS 14 (2004).
149. Id. at 26.
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contaminated food and 420,000 die every year, resulting in the loss of 33 million
healthy life years (DALYs)." 5 o
In the 1960s, globally accepted international standards were proposed as the
solution to the food adulteration and contamination problems that accompanied
trade in food."'1 Those standards would, in theory, ensure that quality measures
adopted in one country could be verified in a second or third country where the
food was ultimately sold. The Codex Alimentarius Europaeus, a forerunner of the
international regulatory framework that exists today, issued standards and guide-
lines for producers, regulators, and courts that achieved some of these aims in the
European context.15 2 By 1963, the Food and Agricultural Organization of the
U.N., WHO, and Codex Alimentarius Europeaus partnered to form the Codex
Alimentarius Commission (Codex), with a goal of creating a global set of food
safety, testing, labeling, and nutrition standards.153 Codex sets standards on food
quality and safety, including food commodity standards and codes of hygienic or
technological practice.15 4 "In addition, Codex evaluates pesticides, food a ditives
and veterinary drugs, establishes limits for pesticide residues, and creates guide-
lines for contaminants."' There are now hundreds of standards, guidelines, and
codes of conduct regulating the international food trade.156
Although Codex's standard development process i  meant to "ensure fair prac-
tices in food trade" and "protect the health of consumers,"15 it has leaned toward
the trade liberalization component of that mission. Section II.A.3 explains how
Codex will become an important channel for global health law as it becomes a
more detailed, administrative body of law, not only with respect to its traditional
standard-issue areas but also with respect to broader and steepening global health
threats like antimicrobial resistance. Because Codex standards provide the bench-
mark against which food quality and safety measures are assessed when disputed
under international-trade rules, the incorporation of health protections into Codex
processes will become more important as "global health common law" develops
through adjudicative bodies.
150. Food Safety, WHO (Apr. 30, 2020), https://www.who.int/news-room/fact-sheets/detail/food-safety
[https://perma.cc/GM9T-QTDF].
151. See Halabi & Lin, supra note 131, at 267.
152. Franz Vojir et al., The Origins of a Global Standard for Food Quality and Safety: Codex
Alimentarius Austriacus and FAO/WHO Codex Alimentarius, 82 INT'L J. VITAMIN & NUTRITION RES.
223, 226 (2012).
153. See id.
154. See A.W. Randell & A.J. Whitehead, Codex Alimentarius: Food Quality and Safety Standards
for International Trade, 16 REVUE SCIENTIFIQUE ET TECHNIQUE DE L'OFFICE INT'L DES EPIZOOTIEs 313,
316-17 (1997).
155. Halabi, supra note 147, at 407.
156. See generally Codex Alimentarius International Food Standards, FOOD & AGRIC. ORG., http://
www.fao.org/fao-who-codexalimentarius/codex-texts/list-standards/en/ [https://perma.cc/N7PL-N7PA]
(last visited Jan. 7, 2020).
157. Halabi & Lin, supra note 131, at 271.
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2. The Global Law of Animal and Plant Health
Though there were nascent efforts to address threats to animal health (the
Office International des Epizooties (OIE) or Organization for Animal Health) as
early as 1924, and for plants as early as 1929 (the International Convention for
the Protection of Plants),15 8 global health law from its establishment in 1948 was
primarily concerned with humans stripped from the environment-including
plants and animals-in which they lived. As this anthropocentric model appeared
to succeed, with more humans living longer and healthier, the result was
expanded encroachment into the environment. This, in turn, caused significant
changes to the nature and severity of threats to human health.
For example, one consequence of the Green Revolution's success meant that
land yielding greater quantities of cereals and grains could be rededicated to live-
stock production.15 9 Global livestock production has consequently exploded since
the 1960s-"[b]eef production has more than doubled, while over the same time
chicken meat production has increased by a factor of nearly 10, made up of
increases in both number of animals and productivity."160 In low- and middle-
income countries, "[t]he share of the world's poultry meat consumed ... rose
from 43 to 54 percent between 1990 and 2005 ... . Further, the proportion of the
world's poultry meat produced in developing countries rose from 42 to 57 per-
cent."161 This production and consumption "will increase by 3.6 percent and 3.5
percent, respectively," annually until at least 2030 "because of rising incomes,
diversification of diets and expanding markets."16 2
More land dedicated to more livestock has resulted in increased interactions
between humans and animals, both domesticated and wild. As those parts of the
ecosystem interact, they give rise to increased channels for pathogens to migrate
from wild animals to livestock to humans. The 2005 H5N1 avian-influenza out-
break produced a terrifying 50% fatality rate, primarily among humans who
158. Shakeel Bhatti, The International Treaty on Plant Genetic Resources, in NAT'L RESEARCH
COUNCIL, DESIGNING THE MICROBIAL RESEARCH COMMONS: PROCEEDINGS OF AN INTERNATIONAL
SYMPOSIUM (Paul F. Uhlir ed., 2011), https://www.ncbi.nlm.nih.gov/books/NBK91499/pdf/
BookshelfNBK91499.pdf [https://perma.cc/FAC4-7W9E]; 3 HORTICULTURE: PLANTS FOR PEOPLE
AND PLACES 1179 (Geoffrey R. Dixon & David E. Aldous eds., 2014); Alejandro B. Thiermann,
International Animal Health Regulations and the World Animal Health Information System, in INST.
OF MED., INFECTIOUS DISEASE MOVEMENT IN A BORDERLESS WORLD: WORKSHOP SUMMARY 246
(2010), https://www.ncbi.nlm.nih.gov/books/NBK45728/pdf/BookshelfNBK45728.pdf [https://
perma.cc/89LN-DXF7].
159. See Food & Agric. Org., Lessons from the Green Revolution: Towards a New Green Revolution,
WORLD FOOD SUMMIT para. 4.7 (1996), http://www.fao.org/3/w2612e/w2612e06a.htm [https://perma.
cc/7843-KQBV].
160. Philip K. Thornton, Livestock Production: Recent Trends, Future Prospects, 365 PHL.
TRANSACTIONS ROYAL Soc'Y B 2853, 2854 (2010).
161. CLARE NARROD, MARITEs TIONGCO & ACHLLES COSTALES, FOOD & AGRIC. ORG., GLOBAL
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worked directly with infected birds.163 Although the precise origin remains
unknown, the COVID-19 coronavirus is likely to have emerged from a live ani-
mal market or from agricultural animals.16
Moreover, the overuse of antibiotics in the livestock-raising process has made
even old pathogens more dangerous as bacteria develop resistance to inappropri-
ately used antibiotics.16 5 OIE, FAO, and WHO, as a result, have increasingly
focused on global legal instruments to control these threats to human health.
a. New and Reemerging Pathogens.
In addition to poultry, much of this growth has revolved around pigs, another
important host for human pathogens.166 "Pathogens" refer to bacteria, viruses,
and other microorganisms that cause disease. 16 The problems of new and re-
emerging pathogens have arisen because of aforementioned shifts in human pop-
ulation growth, behavior, and consumption. New or "emerging" pathogens are
those that have newly appeared in a population or have been present but swiftly
increase in incidence or geographic range.1 68 Recent examples include COVID-
19, HIV/AIDS and Lyme disease.169 Many of these pathogens emerge at conver-
gence points between humans, livestock, and wildlife. Today, more than 50% of
known pathogens infectious to humans are shared with animals (zoonotic dis-
eases) and occur through recurring transmission or an initial spillover event.170
Worldwide, "more than 1 billion infections and 1 million deaths annually are at-
tributable to zoonoses[] and vector-borne diseases."171
As the human population grows, more land is claimed for food production, and
more interactions between humans and animals (including their parasites) result.
For example, infected bats are important carriers of the Nipah virus, which is
163. See Samson S.Y. Wong & Kwok-yung Yuen, Avian Influenza Virus Infections in Humans, 129
CHEST 156, 156 (2006).
164. Graham Readfearn, How Did Coronavirus Start and Where Did It Come From? Was It Really
Wuhan's Animal Market?, GUARDIAN (Apr. 27, 2020, 8:46 PM), https://www.theguardian.com/world/
2020/apr/1 3/how-did-the-coronavirus-start-where-did-it-come-from-how-did-it-spread-humans-was-it-
really-bats-pangolins-wuhan-animal-market [https://perma.cc/V72H-CCV8].
165. See Michael J. Martin & Thomas B. Newman, Antibiotics Overuse in Animal Agriculture: A
Call to Action for Health Care Providers, 105 AM. J. PUB. HEALTH 2409, 2409 (2015).
166. See WORLD BANK, MINDING THE STOCK: BRINGING PUBLIC POLICY TO BEAR ON LIVESTOCK
SECTOR DEVELOPMENT, REPORT No. 44010-GLB 47-49 (2009), http://documents.worldbank.org/curated/
en/573701468329065723/pdf/440100ESWOwhitOBoxO338899B1PUBLIC1.pdf [https://perma.cc/AR62-
2HYJ].
167. Liise-anne Pirofski & Arturo Casadevall, Q&A: What Is a Pathogen? A Question That Begs the
Point, 10 BMC BIOLOGY, Jan. 2012, at 1.
168. Stephen S. Morse, Factors in the Emergence of Infectious Diseases, 1 PERSP. 7, 7 (1995).
169. Id.; Ali M. Messenger et al., Reverse Zoonotic Disease Transmission (Zooanthroponosis): A
Systematic Review of Seldem-Documented Human Biological Threats to Animals, 9 PLOS ONE, Feb.
2014, at 6.
170. Cf. van Helden, van Helden & Hoal, supra note 17, at 498.
171. Advancing a 'One Health' Approach to Promote Health at the Human-Animal-Environment
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transmitted through contact with infected livestock or by eating fruit contami-
nated with bats' urine or saliva.172 As those interactions multiply in the context of
climate change and urbanization, both of which contribute to emergence and
spread, conditions for outbreaks ripen.173 Indeed, annual population growth is
exploding in areas that surround wildlife reserves, where these transmissions are
likely to occur.14
The ease with which humans cross the world means those outbreaks are
more likely to become epidemics or pandemics than in previous decades.175 For
most of history, human populations have been isolated from one another.
Transcontinental exploration, the expansion of communication, and armed con-
flict have fundamentally changed these circumstances. The frequency, velocity,
and volume of passengers by air, land, and sea transportation modes facilitate
transfer of pathogens and vectors further, faster, and in significantly larger num-
bers than ever before.176 A person's ability to reach almost any part of the world
within the incubation period of disease with multiple stops and layovers means
that travelers are important carrier risks for diseases.177 The increased transporta-
tion of bacteria through global travel and trade can turn what would have been a
local outbreak into a pandemic.
The future of global health law is therefore necessarily the law of the human
environment, in ways detailed in section II.B.
b. Antimicrobial Resistance.
Linked to the problem of new and reemerging pathogens and the growth in
livestock agriculture worldwide is the overuse of antibiotics and the accompany-
ing rise of antimicrobial resistance, one of the most serious and worsening threats
to the fight against infectious disease. "Antimicrobial" agents or therapies kill or
slow the spread of bacteria, viruses, or other microorganisms that may cause dis-
ease, or pathogens. "Antibiotics" specifically act against bacterial infections.
Properly administered antibiotics kill illness-causing bacteria or limit bacteria's
ability to multiply, allowing the immune system to effectively respond.178
172. Nipah Virus, WHO (May 30, 2018), https://www.who.int/news-room/fact-sheets/detail/nipah-
virus [https://perma.cc/4AJV-5N9Q].
173. Johanna F. Lindahl & Delia Grace, The Consequences of Human Actions on Risks for Infectious
Diseases: A Review, 5 INFECTION ECOLOGY & EPIDEMIOLOGY, Nov. 2015, at 2.
174. Lucas N. Joppa, Scott R. Loarie & Stuart L. Pimm, On Population Growth Near Protected
Areas, 4 PLoS ONE, Jan. 2009, at 1.
175. See Why It Matters: The Pandemic Threat, CTRS. DISEASE CONTROL & PREVENTION, https://
www.cdc.gov/globalhealth/healthprotection/fieldupdates/winter-2017/why-it-matters.html [https://perma.
cc/L46Z-AN6A] (last updated May 4, 2020).
176. See Mary E. Wilson, Global Travel and Emerging Infections, in INST. OF MED., supra note 158,
at 90.
177. Id.
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"Antimicrobial resistance" describes traits and genetic elements, developed
and then disbursed, by which infectious bacterial pathogens survive current anti-
biotic treatments and then pass on those traits.179 This development threatens not
only the infected animal or human but also the broader community that now col-
lectively faces pathogenic bacteria that are more difficult to fight.
Antimicrobial resistance renders current, relatively inexpensive medicines for
treating infectious diseases "less effective or useless."8 0 The decline in efficacy
of these medicines endangers lives and raises the costs of medical treatment,
because infections from resistant pathogens prolong illness, increase the likeli-
hood of hospitalization (where hospitals are available), and enlarge financial
losses attributable to inability to work and redirection of family care.81 "These
drug-resistant bacteria, or 'superbugs,' present a serious and worsening threat to
human health."18 2
Although there are multiple sources from which antibiotic-resistant bacteria
may develop, "[f]arming practices are largely to blame for the rise of antibiotic-
resistant strains."183 Significant quantities of antibiotics have been used for pro-
motion of growth and treatment of infections among farm animals and in aqua-
culture.184 Antibiotics are commonly used for routine, nontherapeutic application
in food animal production to promote growth and to anticipate the effects of
crowded and unhygienic conditions.8" Industrial farm animals release resistant
bacteria in their feces, and resistant bacteria may be secreted into the environment
through the animal's feces or contaminated skin.186 When manure is applied to
farmland as fertilizer, it may contaminate crops with antibiotic resistant bacte-
ria.187 Water runoff from industrial farms can carry resistant bacteria nd unmeta-
bolized antibiotics into the water supply and, as a result, contaminate drinking
water.188
The World Health Organization has noted the public threat posed by excessive
antibiotic use in animals, declaring that "widespread use of antimicrobials for dis-
ease control and growth promotion in animals has been paralleled by an increase
in resistance in those bacteria ... that can spread from animals, often through
179. See What Is Microbial Resistance?, WHO (July 2017), https://www.who.int/features/qa/75/en
[https://perma.cc/NV48-DKQN].
180. See Gail Hansen, Antibiotic Resistance, in GLOBAL MANAGEMENT OF INFECTIOUS DISEASE
AFTER EBOLA 87, 87 (Sam Halabi, Lawrence 0. Gostin & Jeffrey S. Crowley eds., 2016).
181. Id. at 87.
182. Id. at 88.
183. Donald Kennedy, Editorial, Time to Deal with Antibiotics, 342 SCIENCE 777, 777 (2013).
184. See Vangelis Economou & Panagiota Gousia, Agriculture and Food Animals as a Source of
Antimicrobial-Resistant Bacteria, 8 INFECTION & DRUG RESISTANCE 49, 50 (2015).
185. See Timothy F. Landers et al., A Review ofAntibiotic Use in Food Animals: Perspective, Policy,
and Potential, 127 PUB. HEALTH REP. 4, 6 (2012).
186. See Hansen, supra note 180, at 89.
187. Romain Marti et al., Impact of Manure Fertilization on the Abundance of Antibiotic-Resistant
Bacteria and Frequency of Detection of Antibiotic Resistance Genes in Soil and on Vegetables at
Harvest, 79 APPLIED & ENVTL. MICROBIOLOGY 5701, 5701 (2013).
188. Fabio Kaczala & Shlomo E. Blum, The Occurrence of Veterinary Pharmaceuticals in the
Environment: A Review, 12 CURRENT ANALYTICAL CHEMISTRY 169, 170 (2016).
2020] 1635
THE GEORGETOWN LAw JouRNAL [Vol. 108:1607
food, to cause infections in humans."1 89 WHO has advocated that the "[u]se of
antimicrobial growth promoters ... in humans and animals should be terminated
or rapidly phased-out in the absence of risk-based evaluations."190 Although
scholars have advocated for the use of an Article 19 treaty to address antimicro-
bial resistance, to date WHO has only issued Article 23 recommendations, pri-
marily because they "offer a nimbler, more adaptive option" in the current state
of political sensitivities on the issue.1 91
C. INTERNATIONAL PEACE AND SECURITY
The United Nations Charter is the foundational post-World War II treaty ori-
ented toward a peaceful international order, where the regulation of armed force
to settle international disputes, albeit with important qualifications, is vested in
the U.N. Security Council.192 The powers given to the Council under Chapter VII
do not expressly address global health threats.193 Article 39 of the U.N. Charter
authorizes the Council to counteract "threats to the peace, breaches of the peace,
and acts of aggression."194 Yet global health challenges are emerging as a recur-
rent and critical component of the Security Council's agenda.
The 1980s and 1990s witnessed the emergence of new infectious diseases like
HIV and viral hemorrhagic fevers, both of which have become subjects of U.N.
Security Council action.1 95 Scientists discovered the virus that caused AIDS in
1983.196 By the end of 1986, 85 countries had reported 38,401 cases of AIDS to
WHO: 2,323 in Africa, 31,741 in the Americas, 84 in Asia, 3,858 in
189. How Antibiotic Resistance Happens, PEW CHARITABLE TRs., https://www.pewtrusts.org/~/media/
legacy/uploadedfiles/phg/content_1eveLpages/issue briefs/antibioticesistancepdf.pdf [https://perma.cc/33LK-
7798] (last visited Feb. 2, 2020).
190. WHO, WHO GLOBAL PRINCIPLES FOR THE CONTAINMENT OF ANTIMICROBIAL RESISTANCE IN
ANIMALS INTENDED FOR FOOD 5 (2000), https://apps.who.int/iris/bitstream/handle/10665/68931/
WHOCDSCSRAPH_2000.4.pdf [https://perma.cc/E28T-BG4M].
191. Ponnu Padiyara, Hajime Inoue & Marc Sprenger, Global Governance Mechanisms to Address
Antimicrobial Resistance, 11 INFECTIOUS DISEASES: RES. & TREATMENT, 2018, at 3.
192. U.N. Charter ch. V. art. 24, ¶ 1 ("In order to ensure prompt and effective action by the United
Nations, its Members confer on the Security Council primary responsibility for the maintenance of
international peace and security, and agree that in carrying out its duties under this responsibility the
Security Council acts on their behalf.").
193. Chapter VII of the Charter authorizes the Council to counteract threats to peace, breaches of
peace, and acts of aggression. U.N. Charter art. 39. Article 42 empowers the Council with the power to
"take such action ... as may be necessary to maintain or restore international peace and security." Id.
art. 42. To invoke its Article 42 powers, the Council need only "consider that measures provided for in
Article 41 would be inadequate or have proved to be inadequate." Id.; Gian Luca Burci, Ebola, the
Security Council and the Securitization ofPublic Health, 10 QUESTIONS INT'L L. 27, 27 (2014) ("This
[UN Security Council Resolution on Ebola] is an unprecedented step in expanding the concept of threat
to international peace and security and implicitly the scope of the powers of the Council under the UN
Charter.").
194. U.N. Charter ch. VII; see id. ch. V. art. 24, ¶ 2 (granting to the Council the powers in Chapter VII).
195. See Fidler & Gostin, supra note 43, at 85.
196. Robert C. Gallo & Luc Montagnier, The Discovery ofHIVas the Cause ofAIDS, 349 NEw ENG.
J. MED. 2283, 2284 (2003).
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Europe, and 395 in Oceania.19 7 By the early 1990s, the HIV/AIDS-afflicted popu-
lation exploded in sub-Saharan Africa, which became home to the vast majority
of people living with HIV/AIDS worldwide.1 98 By 2005, approximately 20 mil-
lion people had died from AIDS, and another 40 million people were infected.1 99
Over the following decade, HIV/AIDS posed a burden of death and disability on
those it afflicted and a threat to international peace and security.
The precursor to the Security Council debate [(in 2000)] was a US National
Intelligence assessment of the security threat posed by infectious diseases,
which singled out HIV/AIDS as the gravest such peril. The National
Intelligence Council report sounded the alarm: "the persistent infectious dis-
ease burden is likely to aggravate and in some cases, may even provoke eco-
nomic decay, social fragmentation and political destabilisation of the hardest
hit countries in the developing world."200
Other infectious diseases also posed significant risks to global security.
Between 1994 and 2000, for example, there were more outbreaks of Ebola Virus
Disease in Africa than there had been in the twenty years before.201 The outbreak
in West Africa between 2014 and 2016 spread to Italy, Spain, and the United
States.2 02 As of this writing, COVID-19 had infected over 1.9 million people
worldwide, and caused more than 119,000 deaths.203
These infectious disease threats caused the U.N. Security Council to act upon
both HIV/AIDS and Ebola, deeming them threats on the order of militarized
threats the Council was established to regulate. Between 1981-when the mem-
bers of the World Health Assembly adopted the International Code-and 1994,
when the World Trade Organization was established, the relationship between
free movement of goods, global health law, and human welfare was focused
197. History of HIV and AIDS Overview, AVERT, https://www.avert.org/professionals/history-hiv-
aids/overview [https://perma.cc/299J-4GYJ] (last visited Jan. 8, 2020).
198. AIDS IN THE WORLD II: GLOBAL DIMENSIONS, SOCIAL ROOTS, AND RESPONSES 18-23 (Jonathan
M. Mann & Daniel J.M. Tarantola eds., 1996).
199. Thomas Goliber, The Status of the HIV/AIDS Epidemic in Sub-Saharan Africa, POPULATION
REFERENCE BUREAU (July 2, 2002), https://www.prb.org/thestatusofthehivaidsepidemicinsub
saharanafrica/ [https://perma.cc/9J2A-D63F]; The Global HIV and AIDS Epidemic, 2001, 50 CDC
MORBIDITY & MORTALITY WKLY. REP. 434 (June 1, 2001), https://www.cdc.gov/mmwr/preview/
mmwrhtml/mm5021a3.htm [https://perma.cc/KCH7-KDGP].
200. Alex de Waal, The Art ofMedicine: HIV/AIDS and the Challenges of Security and Conflict, 375
LANCET 22, 22 (2010).
201. Martiner, Chronology of Ebola Virus Disease Outbreaks, 1976-2014, HEALTH INTELLIGENCE
(June 10, 2014), http://publichealthintelligence.org/content/chronology-ebola-virus-disease-outbreaks-
1976-2014 [https://perma.cc/L4WZ-UEYY].
202. 2014-2016 Ebola Outbreak in West Africa, CTRS. DISEASE CONTROL & PREVENTION, https://
www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html [https://perma.cc/96PE-2M3Q] (last
updated Mar. 8, 2019).
203. Coronavirus Resource Center, JOHNS HOPKINS U. & MED., https://coronavirus.jhu.edu/ [https://
perma.cc/3Q9V-J86C].
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through not only the HIV/AIDS crisis, but a broadening spectrum of health
threats faced primarily by poor populations.20
In 1994, the U.N. Economic and Social Council (ECOSOC) passed resolution
1994/24, which endorsed the establishment of a Joint United Nations Programme
on HIV/AIDS, UNAIDS. 205 UNAIDS was founded to be the successor of the
Global Programme on AIDS of WHO, which had led the fight against AIDS since
1986.206 The creation of UNAIDS came as the result of the recognition of the
insufficiency of the medically based AIDS approach of WHO's Global
Programme and "the need for a multisectoral response to the complex challenges
of the HIV/AIDS pandemic, including the social, economic, and development
issues contributing to the spread of the virus."207
In 2000, the U.N. Security Council unanimously adopted Resolution 1308,
marking the first time that a health issue was deemed a threat to international
peace and security.208 The Security Council tied its own recommendations for
action to the integrity of international peacekeeping operations, but it was clear
that the resolution was more broadly intended, noting as it did "that the spread of
HIV can have a uniquely devastating impact on all sectors and levels of soci-
ety." 2 09 In 2011, the U.N. Security Council expanded its recommendations,
emphasizing that "urgent and coordinated international action continues to be
required to curb the impact of the HIV epidemic in conflict and post-conflict
situations."2 10
In 2014, the U.N. Security Council adopted Resolution 2177 in light of the
International Health Regulations' failure to adequately address the Ebola epi-
demic in Guinea, Liberia, and Sierra Leone.2 11 Neighboring and distant states
implemented trade and travel restrictions inconsistent with the WHO Director-
General's recommended measures after a public health emergency of intema-
tional concern was declared (the triggering acknowledgement for legal authorities
under the International Health Regulations), and the U.N. Security Council
stepped in as a "Global Health Keeper," establishing the U.N. Mission for Ebola
Emergency Response (UNMEER) as a temporary measure to meet immediate
needs related to the fight against Ebola.212
204. See, e.g., UN MILLENNIUM PROJECT, PRESCRIPTION FOR HEALTHY DEVELOPMENT: INCREASING
ACCESS TO MEDICINES 9 (2005).
205. Economic and Social Council Res. 1994/24 (July 26, 1994).
206. UNAIDS, Facts About UNAIDS 1 (Oct. 1996), http://data.unaids.org/publications/irc-pub03/
una96-2_en.pdf [https://perma.cc/5PCW-GWJV].
207. U.S. GEN. ACCOUNTING OFFICE, GAO-01-625, JOINT U.N. PROGRAMME ON HIV/AIDS NEEDS
TO STRENGTHEN COUNTRY-LEVEL EFFORTS AND MEASURE RESULTS 4-5 (2001).
208. S.C. Res. 1308 (July 17, 2000).
209. Id.
210. S.C. Res. 1983 (June 7, 2011).
211. S.C. Res. 2177 (Sept. 18, 2014).
212. See Ilja Richard Pavone, Ebola and Securitization of Health: UN Security Council Resolution
2177/2014 and Its Limits, in THE GOVERNANCE OF DISEASE OUTBREAKS 301, 302, 323 (Leonie Vierck,
Pedro A. Villarreal & A. Katarina Weilert eds., 2017).
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As of this writing, the U.N. Security Council held its first meeting about declar-
ing COVID-19 a threat to international peace and security.213 The failure of it to
do so was not for lack of consensus about the threat but about the disagreement
between the United States and China regarding the wording of its origin.214
11. THE FUTURE OF GLOBAL HEALTH LAW
The shifts in global health law have driven it from its twentieth-century home
in the lawmaking authorities of the WHO Constitution and toward a wider, more
diverse range of international actors, including other U.N. agencies, the WTO,
international arbitral tribunals, the U.N. Security Council, and large enterprises in
health-related sectors like food, medicine, and tobacco. Whereas the origins of
global health law were in formal treaties and regulatory instruments like the
International Sanitary Regulations and the International Health Regulations, the
future of global health law lies in what would have formerly been understood as
"private" or quasi-private law: administrative law, the law of contracts between
large entities, and the law of tort. Just as influential as the number of players in
global health law is the scope of its applicability. Urbanization and climate
change have made the surveillance and regulation of animals (domesticated and
wild) critical components of "one-health" approaches to human health and there-
fore the kinds of issues that global health law must address.
A. REGULATING FIRMS AND THEIR PARTNERSHIPS
Section L.A analyzed how WHO activities over the course of the 1950s and
1960s led to increasing focus on infant and child health and the corresponding
influence, much of it adverse, that large firms exercised upon infant, child, and
adolescent health. This section explicates the international dynamics that will
facilitate the development of additional supranational regulatory egimes, legal
frameworks for public-private partnerships, and administrative changes in world
investment and trade law that will correspondingly make regulation more inte-
grated with, and influenced by, global health law.
1. Supranational Regulation
There are two fundamental dynamics that will push global health law toward
the development of more international treaties and supranational legal instru-
ments aimed at directly regulating firms.2 15 The first is the increasing importance
of low- and middle-income markets to global firms with products and services
213. UN Security Council to Discuss COVID-19 Pandemic in Closed Session on Thursday, ECON.




215. "Supranational law" has been defined as "law which goes beyond the national law and
prevails." Kristi Joamets, Gender as an Element of Marriage Capacity in the Context of National and
Supranational Law in the European Union 10 (Oct. 7, 2014) (unpublished Ph.D. thesis, Tallinn
University of Technology).
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uniquely affecting individual and public health.216 The second is the persistent
need and desire for low- and middle-income countries to use collective action to
address firm behavior. Theoretically, it is possible for each country, as a sover-
eign lawmaker, to regulate firm behavior within its jurisdiction. Practically, laws
like the Framework Convention on Tobacco Control and the International Code
of Marketing of Breast-milk Substitutes have emerged because those countries
realize that their internal lawmaking processes are vulnerable to influence from
global firms. They further realize that they are likely to achieve greater gains vis-
a-vis those firms through collective, global health law instruments.
"The 1981 International Code of Marketing of Breastmilk Substitutes is effec-
tively a Nestl6-specific treaty."217 Even in 1981, Nestl6 controlled 50% of the
global infant formula market.2 18 Developing countries were unified in their posi-
tions with respect to Nestl6 (and to some extent, the small number of competitor
firms all based in wealthy countries) that breastmilk substitutes contributed little
to their national economies and, by increasing infant morbidity and mortality,
generated unnecessary healthcare costs. This unity of position, and the necessity
of a supranational regulatory instrument to give effect to their consensus, is
expressed in the strength of the Code vote (118 in favor, 1 against, and 3 absten-
tions).219 Similarly, not only Nestl6, but diplomats from wealthier countries,
viewed the Code as a regulatory assertion from WHO and understood it to be the
first of more such regulatory instruments to follow.220
The lessons of the International Code informed the debate leading to the nego-
tiation and adoption of the Framework Convention on Tobacco Control.221
Nongovernmental organizations pointed to the International Code as showing the
pathway toward civil-society engagement with the treaty-making process.2 22 As
with the formula sector as it existed in the late 1970s and the early 1980s, the
216. See Anna Gilmore, Big Tobacco Targets the Young in Poor Countries - with Deadly
Consequences, GUARDIAN (Dec. 1, 2015, 6:57 AM), https://www.theguardian.com/global-development/
20 15/dec/0 1/big-tobacco-industry-targets-young-people-poor-countries-smoking [https://perma.cc/
XRX5-5535].
217. HALABI, supra note 21, at 220.
218. Solomon, supra note 58.
219. See Sikkink, supra note 85, at 822.
220. See id. at 820 ("Kenneth L. Adelman, when U.S. deputy representative to the United Nations,
wrote that 'it appears that the infant formula drive was just the opening skirmish in a much larger
campaign.... And this larger campaign could reach beyond regulation of pharmaceuticals to encompass
United Nations codes on hazardous chemicals, transborder ata flow, and an array of so-called consumer
protection activities."').
221. See Roemer et al., supra note 98, at 937.
222. See WHO, Framework Convention on Tobacco Control, Technical Briefing Series Paper 3,
Mobilizing NGOs and the Media Behind the International Framework Convention on Tobacco Control,
at 17-20 (1999), https://apps.who.int/iris/bitstream/handle/10665/65357/WHO NCDTFI_99.3.pdf
[https://perma.cc/G2CV-ALGA].
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tobacco industry in the late 1990s and early 2000s was highly consolidated, with
common overlapping practices worldwide.2 23
When Canada, Finland, Tanzania, and Mexico introduced the idea of a global
tobacco control treaty at WHO, four corporations controlled 75% of the global
market and the broad perception was that only a supranational regulatory instru-
ment could effectively address their international activities.22 4 The global tobacco
industry put the conceptual notion of supranational regulation at the core of its
fierce resistance to the Framework Convention on Tobacco Control.225 Philip
Morris endeavored generally to discredit WHO as a tobacco regulatory body and
sought to weaken the treaty through its influence on national delegations.226
Supranational regulation has now moved beyond product sectors that affect
individual and public health and toward the broader healthcare sector. Less oli-
gopolistic, but nevertheless global, firms have long recruited healthcare workers
trained abroad to fill understaffed areas in the United States, especially in rural
regions and other underserved populations.22 7 Active recruitment by private
recruitment agencies greatly contributes to the depletion of health workforces in
many low- and middle-income countries.2 28 "Australia, Canada, the United
Kingdom (UK) and United States (USA) account for 72% of foreign-bom nurses
and 69% of foreign-bom physicians. "229 Those countries have collectively saved
billions in costs "by recruiting physicians from countries in sub-Saharan Africa-
countries that lose 30% of their trained health workers annually to medical emi-
gration."23 0 In 2010, WHO adopted the Global Code of Practice on the
International Recruitment of Health Personnel, which makes clear that it is appli-
cable to "recruiters, employers, health-professional organizations, relevant subre-
gional, regional and global organizations, whether public or private sector,
223. Katherine DeLand et al., The WHO Framework Convention on Tobacco Control and the
Tobacco Free Initiative, in THE GLOBAL TOBACCO EPIDEMIC AND THE LAW 11, 13 (Andrew D. Mitchell
& Tania Voon eds., 2014).
224. Id. at 13-14; Thomas Bollyky & David Fidler, Has a Global Tobacco Treaty Made a
Difference?, ATLANTIC (Feb. 28, 2015), https://www.theatlantic.com/health/archive/2015/02/has-a-
global-tobacco-treaty-made-a-difference/386399/.
225. See, e.g., Brown & Williamson Tobacco Corporation, Comments on the World Health
Organization Framework Convention on Tobacco Control 2-3 (Mar. 29, 2000), http://legacy.library.
ucsf.edu/tid/uri45a99 [https://perma.cc/DAZ6-K87X].
226. See H.M. Mamudu & S.A. Glantz, Civil Society and the Negotiation of the Framework
Convention on Tobacco Control, 4 GLOBAL PUB. HEALTH, 2009, at 10.
227. Giorgio Cometto et al., Health Workforce Brain Drain: From Denouncing the Challenge to
Solving the Problem, 10 PLoS MED., Sept. 2013, at 1.
228. Lisa A. Eckenwiler, Care Worker Migration and Transnational Justice, 2 PUB. HEALTH
ETHICS 171, 173-74 (2009); Christoph Aluttis et al., The Workforce for Health in a Globalized Context -
Global Shortages and International Migration, 7 GLOBAL HEALTH ACTION, 2014, at 3.
229. Vivian Tam et al., Empirically Evaluating the WHO Global Code of Practice on the
International Recruitment of Health Personnel's Impact on Four High-Income Countries Four Years
After Adoption, 12 GLOBALIZATION & HEALTH, 2016, at 2.
230. Id.
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including nongovernmental, and all persons concerned with the international
recruitment of health personnel."23 1
Calls for similar supranational or international agreements have followed on
other global health law matters such as excessive alcohol consumption, antibiotic
resistance, counterfeit medicines, and corruption in health systems.23 2
2. Public-Private Partnerships
Global health law will not only be characterized by additional supranational
regulation of global firms but also by the contractual agreements that regulate
relationships between firms and public-sector partners. Because public-private
partnerships have proliferated since 2000 (with the establishment of GAVI, fol-
lowed by the Global Fund to Fight AIDS, Tuberculosis and Malaria in 2002), the
contractual relationships between firms, governments, and large health-oriented
foundations will serve as a significant source of global health law. Consider the
Pandemic Influenza Preparedness Framework described in section I.A.1.c. On
one hand, pharmaceutical firms viewed the arrangement as a form of suprana-
tional regulation: "The negotiations over the establishment of the WHO
Pandemic Influenza Preparedness Framework Agreement were viewed, at least
by the IFPMA, as fundamentally about what level of supranational regulation
would be imposed for them to participate in the Global Influenza Surveillance
and Response System for virus samples with pandemic potential."23 3 On the other
hand, the system works through standard material-transfer agreements establish-
ing the rights and obligations between the companies and WHO.2 3 4
GAVI similarly operates under agreements between itself (technically a Swiss
foundation), vaccine manufacturers, and governments procuring the vaccines.235
The procuring agency is UNICEF (and, for some stockpiles of vaccines, WHO),
and the terms of UNICEF acquisition are imposed on firms as well. 236 These
terms include responsibility for other aspects of vaccines that may affect health,
like side effects or adverse reactions.
The Global Fund similarly administers its mandate through contractual
arrangements. The Global Fund is the main multilateral funder in global health
231. WHO, WHO Global Code of Practice on the International Recruitment of Health Personnel,
WHA63.16, art. 2.2 (May 2010); see also Amani Siyam et al., Monitoring the Implementation of the
WHO Global Code of Practice on the International Recruitment ofHealth Personnel, 91 BuLL. WORLD
HEALTH ORG. 816, 816 (2013) ("The adoption in 2010 of the WHO Global Code of Practice ...
furnished a guide to international cooperation and facilitated a platform for continuing dialogue on the
critical problem of health worker migration.").
232. Bollyky & Fidler, supra note 224.
233. HALABI, supra note 21, at 220.
234. WHO, Pandemic Influenza Preparedness: Sharing of Influenza Viruses and Access to Vaccines
and Other Benefits, supra note 125, at 14.
235. See Susan K. Sell, The Quest for Global Governance in Intellectual Property and Public
Health: Structural, Discursive, and Institutional Dimensions, 77 TEMP. L. REv. 363, 371 (2004).
236. See generally United Nations Children's Fund [UNICEF], UNICEF Vaccine Procurement
Overview: Priorities, Status and Way Forward, https://perma.cc/QFU4-WK4Q (explaining UNICEF's
procurement role).
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and channels 69% of the international financing for TB 237 and more than 20% of
the international financing against AIDS.238 It also funds "health systems
strengthening, as inadequate health systems are one of the main obstacles to scal-
ing up interventions to secure better health outcomes for HIV, TB and
malaria."23 9 Grants are awarded to Principal Recipients, entities that enter into
agreements with the Fund.240 The Principal Recipients are the grants' lead imple-
menters and are responsible for program management.24 1 Country Coordinating
Mechanisms (CCMs) evaluate proposals within a particular country and send
coordinated proposals to the Global Fund.242 The CCMs also share governance
with Principal Recipients, who are also members of the CCMs.243
Large, influential foundations like the Bill and Melinda Gates Foundation and
the Wellcome Trust similarly use legally binding agreements to shape the behav-
ior of health-related actors. The Gates Foundation is part of the governance of
GAVI, the Global Fund, and other public-private partnerships specific to disease
research like HIV/AIDS. Gates Foundation funding is accompanied by require-
ments that recipients allow "unrestricted access and reuse of all peer-reviewed
published research funded, in whole or in part, by the foundation, including any
underlying data sets."244 These requirements similarly inform agreements entered
into by the organizations in which the Gates Foundation plays a management
role, like the Global Fund and GAVI. The Wellcome Trust also requires the dis-
closure of research and the publication of data in open-access fora.2 45 The future
of global health law is therefore not only likely to be shaped by supranational reg-
ulation, primarily by WHO, but also by the tightening network of agreements
required by international funders.246
The Coalition for Epidemic Preparedness Innovations (CEPI), an international
public-private partnership committed to developing vaccines for otherwise
237. Tuberculosis, GLOBAL FUND (May 2, 2019), https://www.theglobalfund.org/en/tuberculosis/
[https://perma.cc/VD3P-DMDF].
238. Funding for HIV and AIDS, AVERT (May 25, 2018), https://www.avert.org/professionals/hiv-
around-world/global-response/funding [https://perma.cc/8XJ6-46FJ].
239. Fighting AIDS, Tuberculosis and Malaria, GLOBAL FUND, https://perma.cc/CK6T-DNE4 (last
visited May 18, 2020).
240. Anna Triponel, Global Fund to Fight Aids, Tuberculosis and Malaria: A New Legal and
Conceptual Framework for Providing International Development Aid, 35 N.C. J. INT'L L. & COM. REG.
173, 198 (2009).
241. Id.
242. Id. at 197.
243. Id. at 197-98.
244. Bill & Melinda Gates Foundation Open Access Policy, BLL & MELINDA GATEs FOUND. https://
www.gatesfoundation.org/how-we-work/general-information/open-access-policy [https://perma.cc/JTA6-
NKWP] (last visited Jan. 9, 2020).
245. See Open Access Policy, WELLCOME, https://wellcome.ac.uk/funding/guidance/open-access-
policy [https://perma.cc/QC7Y-RNGP] (last visited Feb. 3, 2020).
246. See, e.g., Michelle Rourke, Sam Halabi, Gian Luca Burci & Rebecca Katz, The Nagoya
Protocol and the Legal Structure of Global Biogenomic Research, 41 YALE J. INT'L L. 1 (forthcoming
2020) (manuscript at 2).
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neglected diseases, now funds eight vaccine candidates against COVID-19.247
CEPI's equitable-access policy requires that vaccines it funds "will be priced and
include affordability commitments or standards."248
3. The World Trade Organization, ICSID, and Other Adjudicatory Bodies
Supranational regulation and the agreements forging public-private partner-
ships for health may be thought of as ex ante forms of global health law that will
grow in importance and influence. Ex post global health law may be understood
to be how lawmaking or law-shaping adjudicative bodies integrate ex ante global
health law into their decisions affecting rights between parties-both govem-
ments and firms-when disputes arise that implicate application of that body of
law.249 These bodies are most likely to be arbitral panels like those convened
under the auspices of the International Centre for Settlement of Investment
Disputes (ICSID), courts dedicated to disputes between sovereigns like the
International Court of Justice and the WTO's Dispute Settlement Understanding,
and, of course, national courts. These adjudications have already occurred at a
limited level and are likely to increase, thus expanding the body of global health
law that is judicially informed and shaped.
The most significant incorporation of global health law in one of these tribu-
nals to date was the Doha Declaration on the Trade-Related Aspects of
Intellectual Property Rights (TRIPS) Agreement and Public Health.250 In 1996,
Brazil adopted a "local-working" requirement as part of its Industrial Property
Law, which permitted the Brazilian government to license patented medicines
and technology to other firms for production if the patent was not "worked" in
Brazil.25 1 Pharmaceutical firms, which had exported patented medicines to Brazil
but not produced them there, protested the law and encouraged the U.S. govem-
ment to bring a formal dispute at the WTO for violating TRIPS, the intellectual
property law in the broader WTO Agreements.252 in response to the U.S. com-
plaint, Brazil raised issues of U.S. patent policy that provided allegedly discrimi-
natory support for its pharmaceutical industry.253 As a result of the WTO dispute
247. Dave Kovaleski, CEPI Invests $4.9M in Consortium to Develop COVID-19 Vaccine,
HOMELAND PREPAREDNESS NEWS (Mar. 23, 2020), https://homelandprepnews.com/stories/46200-cepi-
invests-4-9m-in-consortium-to-develop-covid-19-vaccine/ [https://perma.cc/MVD2-2ZDR].
248. Brenda Huneycutt et al., Finding Equipoise: CEPI Revises Its Equitable Access Policy, 38
VACCINE 2144, 2144, 2146 (2020).
249. See generally Leonie Vierck, The Case Law of International Public Health and Why Its Scarcity
Is a Problem, in THE GOVERNANCE OF DISEASE OUTBREAKS, supra note 212, at 113 (arguing that more
ex post law is needed in the global public health field).
250. See generally James Thuo Gathii, The Legal Status of the Doha Declaration on TRIPS and
Public Health Under the Vienna Convention on the Law of Treaties, 15 HARV. J.L. & TECH. 291, 293-
95 (2002); John S. Odell & Susan K. Sell, Reframing the Issue: The WTO Coalition on Intellectual
Property and Public Health, 2001, in NEGOTIATING TRADE: DEVELOPING COUNTRIES IN THE WTO AND
NAFTA 85, 94-96 (John S. Odell ed., 2006).
251. See Article 68 of Law No. 9,279 of May 14, 1996, effective May 1997.
252. Request for the Establishment of a Panel by the United States, Brazil - Measures Affecting
Patent Protection, WTO Doc. WT/DS199/3 (Jan. 9, 2001).
253. See 35 U.S.C. §§ 204, 209 (2012).
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and pressure exerted by African countries bearing the burden of the HIV/AIDS
crisis, WTO Member States adopted the Declaration on the TRIPS Agreement
and Public Health (Doha Declaration) at the Fourth Ministerial Conference, held
in Doha, Qatar, in November 2001.254
Developed to protect access to medicines for HIV/AIDS, tuberculosis, malaria
and "other epidemics," the Doha Declaration established that treatments for dis-
eases affecting low- and middle-income countries required that normal rules of
trade defer to global health interests.255 The United States and Brazil terminated
their dispute in 2001 in the wake of the Doha Declaration, which they jointly
drafted.256 Although accomplished through ministerial action, the Doha Declaration
was effectively the result of international litigation.257
Similarly, the International Code of Marketing of Breast-milk Substitutes has
been incorporated into WTO-relevant instruments to protect infants from trade
challenges to products the Code covers. The Code is specific to a "corporation"
or "any other entity" in the business of breastmilk substitutes and covers not only
infant formula but also "cow's milk, fruit juices, cereals, vegetables, or any other
fluid, solid or semi-solid food intended for infants" when those foods are "mar-
keted or otherwise represented to be suitable" as a substitute.258 The Code author-
izes countries to prevent companies from advertising breastmilk substitutes;
implement strict labeling requirements, including a proscription on infant images
or other pictures that idealize breastmilk substitutes; limit influence on healthcare
workers; and prohibit distribution of free samples of breast milk substitutes.259
Large infant formula markets like Brazil, China, and India have banned the use of
images on infant formula containers,26 0 while a growing number of developing
and wealthy countries are considering stronger measures toward limiting the
appearance or use of trademarks in connection with infant formula.26 1
254. WTO, Ministerial Declaration of 14 November 2001, WTO Doc. WT/MIN(01)/DEC/2 [the
Doha Declaration].
255. Id. ¶ 1; see Elizabeth Chien-Hale & Frederick M. Abbott, Intellectual Property Rights in Global
Trade Framework: IP Trends in Developing Countries, 98 PROC. ANN. MEETING AM. SOc'Y INT'L L.
95, 96 (2004).
256. See Notification of Mutually Agreed Solution, Brazil - Measures Affecting Patent Protection,
WTO Doc. WT/DS199/4 (July 19, 2001).
257. See Sam F. Halabi, International Intellectual Property Shelters, 90 TUL. L. REV. 903, 908
(2016) (arguing that events leading to the Doha Declaration reflect "a single, cohesive phenomenon that
has emerged in response to intellectual property protections expanding through trade and investment
agreements").
258. WHO, INTERNATIONAL CODE OF MARKETING OF BREAST-MILK SUBSTITUTES, supra note 82,
arts. 2-3, annex 3.
259. Id. arts. 5, 7, 9.
260. WHO, COUNTRY IMPLEMENTATION OF THE INTERNATIONAL CODE OF MARKETING OF BREAST-
MILK SUBSTITUTES: STATUS REPORT 2011 26-38 (2013), https://apps.who.int/iris/bitstream/handle/
10665/85621/9789241505987eng.pdf [https://perma.cc/4NLW-ZD7W].
261. See, e.g., Jessica Samakow, Baby Formula Ads in Sweden May Soon Be Banned from Featuring
Babies, HUFF POST (Nov. 8, 2012, 5:03 PM), http://www.huffingtonpost.com/2012/11/08/baby-formula-
ads-sweden-_n_2092920.html [https://perma.cc/E3UW-H5WL]; Aideen Sheehan, EU Bans Photos of
Babies on Formula Milk, IRISH INDEP. (June 12, 2013, 3:04 AM), http://www.independent.ie/irish-news/
eu-bans-photos-of-babies-on-formula-milk-29337896.html [https://perma.cc/4LCD-84G6].
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Measures implementing the International Code are protected from the WTO's
dispute-settlement mechanism, so challenges under TRIPS would be unusually
difficult.262 At the time of WTO's establishment, as well as the TRIPS
Agreement's establishment, countries needed an efficient mechanism by which
to evaluate whether public health and regulatory measures that already existed,
and those that might be adopted in the future, appropriately served regulatory pur-
poses, rather than as hidden means to discriminate against foreign goods.
The answer, at least for food and plant safety, was the list of standards already
adopted by Codex, analyzed in section I.B. Since 1963, Codex had adopted stand-
ards on food quality and safety, including food-commodity standards and codes
of hygienic or technological practice, in an effort to "ensure fair practices in food
trade" and "protect the health of consumers."263 Codex was designated WTO's
official standard reference body for challenges to food safety or labeling meas-
ures under the Sanitary and Phytosanitary (SPS) Agreement.264 All countries that
have acceded to the WTO Agreements may be bound by WTO panel decisions
regarding SPS and TBT measures. Therefore, these countries may be constrained
by Codex standards.2 65 The Agreement instructs WTO Members to "'base their
sanitary or phytosanitary measures on international standards' (Article 3.1) and
presumes those international standards to 'be consistent with the relevant [provi-
sions] of this Agreement and of GATT [General Agreement on Tariffs and
Trade] 1994' (Article 3.2)."266
By 1994, Codex had already adopted the International Code into its "Standard
for Infant Formula and Formulas for Special Medical Purposes Intended for
262. See Halabi, supra note 147, at 414 ("Codex standards on infant formula ... not only tightly
regulate the components of formula (for example, vitamins, minerals, and essential nutrients) but also
incorporate key aspects of the 1981 World Health Organization's International Code on the Marketing
of Breastmilk Substitutes. This is to enable regulatory authorities to require manufacturers to include
labels stating the superiority of breastfeeding for infants, prohibiting pictures of infants or women that
idealize formula use, and advising consumers that hey should use formula only on the advice of an
independent health worker, without falling afoul of the SPS Agreement." (citing Codex Alimentarius
Commission, Codex Standard 72-1981 § 9.6 (2011))).
263. Id. at 407 (citing FOOD & DRUG ADMIN., FDA's INTERNATIONAL FOOD SAFETY CAPACITY-
BUILDING PLAN 21 (2013)).
264. Id. at 412. "The WTO's SPS Agreement was established in 1995 to regulate food, plant, and
animal safety and health regulations. The adjudicatory arm . . . of the WTO resolves trade disputes
regarding such issues and can impose or permit trade-based punitive measures for violations of the SPS
Agreement." Id. at 412 n.58.
265. Michael A. Livermore, Authority and Legitimacy in Global Governance: Deliberation,
Institutional Differentiation, and the Codex Alimentarius, 81 N.Y.U. L. REV. 766, 768-70 (2006). "The
WTO's near codification of Codex Alimentarius standards regarding sanitary and phytosanitary
measures likely casts Codex's SPS-related actions as the organization's most significant activity."
Halabi, supra note 147, at 413 n.60; see Randell & Whitehead, supra note 154, at 316-17.
266. Halabi, supra note 147, at 413 n.61 (quoting Marrakesh Agreement Establishing the World
Trade Organization, Apr. 15, 1994, 1867 U.N.T.S. 154, art. 3); see also David A. Wirth, The
Transatlantic GMO Dispute Against the European Communities, in EU AND WTO LAW: How TIGHT IS
THE LEGAL STRAIGHTJACKET FOR ENVIRONMENTAL PRODUCT REGULATION? 175, 191 (Marc Pallemaerts
ed., 2006).
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Infants."267 Although the Codex standard operates separately from measures
sanctioned by TRIPS, the standard effectively creates a safe harbor for strong
measures regulating infant formula and other foods that might be used as
substitutes.
Though global health law has been increasingly incorporated into adjudica-
tions under international trade law, one of the most significant changes has
occurred in the field of international investment law.2 68 Between 2008 and 2010,
the small, South American country of Uruguay implemented a number of
tobacco-control measures, including two that addressed the manipulation of
packaging and labeling to shape health perceptions of tobacco products.269 First,
the state required that pictorial warnings cover 80% of a cigarette pack's sur-
face.270 Second, the Ministry of Health limited the sale of cigarettes to only one
variety per brand, the so-called single-presentation requirement.271 That part of
the law prevented a firm from selling multiple varieties of cigarettes under a sin-
gle trademark. For example, Philip Morris International (PMI), whose most im-
portant asset is the Marlboro brand, could no longer sell Marlboro "Reds" and
Marlboro "Greens," leaving "Marlboros" as its only authorized variety.272 At the
time the measures were adopted, Uruguay had one of Latin America's highest
smoking rates.273 As of 2009, more than 5,000 Uruguayans died each year from
diseases linked to tobacco consumption, mainly due to cardiovascular diseases
and cancer.2 74
The FCTC effectively protected Uruguay's measures from what would have,
prior to the FCTC's existence, been strong claims that the new laws wrongly
diminished the value of PMI's investment-that is, its trademarks. Philip Morris
International first challenged the regulations in Uruguayan courts, seeking an
injunction based in part on Uruguay's law adopting TRIPS, the treaty at issue for
267. Codex Alimentarius Commission, FAO & WHO, Codex Standard 72-1981, Standard for Infant
Formula and Formulas for Special Medical Purposes Intended for Infants § 9.6.2 (2016).
268. See, e.g., Prathana Rebecca Knapp & Nutthakam Phongphunpunya, Striking a Balance: Public
Health vs IP Rights in Thailand's Cigarette Package Rules (2014), http://gip-asean.com/information/
newsletter201404th.pdf [https://perma.cc/JSY2-FQJS].
269. See Susy Frankel & Daniel Gervais, Plain Packaging and the Interpretation of the TRIPS
Agreement, 46 VAND. J. TRANSNAT'L L. 1149, 1158-59 & n.31 (2013).
270. Uru., Presidential Decree No. 287/009 (June 5, 2009); see FTR Holding S.A. v. Uruguay, ICSID
Case No. ARB/10/17, Request for Arbitration, ¶ 5 (Feb. 19, 2010), http://www.smoke-free.ca/
eng_home/2010/PMvsUruguay/PMI-Uruguay%20complaint0001.pdf [https://perma.cc/P34R-55N3].
271. Uru., Ministry of Public Health Ordinance No. 514 art. 3 (Feb. 14, 2009).
272. FTR Holding S.A. v. Uruguay, Request for Arbitration, ¶ 45 ("As of 31 December 2009, Article
3 of Ordinance 514 has resulted in an approximately 15 per cent decrease in Abal's sales. The hardest hit
brand has been 'Marlboro,' of which the discontinued 'Marlboro Gold,' 'Marlboro Blue' and 'Marlboro
Green (Fresh Mint)' varieties represented 40.5 per cent of total sales in 2008.... As a result of
Ordinance 514, Philip Morris has been prevented from introducing these innovations in Uruguay and
accordingly has been deprived of the use of its intellectual property.").
273. PAN AMERICAN HEALTH ORGANIZATION [PAHO] & WHO, TOBACCO CONTROL REPORT FOR
THE REGION OF THE AMERICAs 3 chart 2 (2013).
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the Doha Declaration dispute described above.275 Unsuccessful in Uruguayan
courts, PMI initiated (through Swiss corporate entities it controlled) arbitration
proceedings under Switzerland's bilateral-investment treaty with Uruguay.2 76
That treaty included not only broad definitions of "investor" and "investment,"
but it also established narrow exceptions for public health regulation and required
laws to compensate an investor for an "indirect" expropriation, even when those
laws were passed under the public health exception and according to due
process.27 7
The international arbitration panel hearing the dispute determined that
Uruguay's measures fell within its obligations under the FCTC, which itself pro-
vided an independent basis that Uruguay's measures were evidence-based and in
the public interest.278 Citing Articles 2, 4, 11, and 13 of the FCTC, the arbitration
panel concluded that:
[The single-presentation requirement (SPR)] is part of Uruguay's comprehen-
sive tobacco control policies and is in line with WHO Recommendations and
Uruguay's express obligations under Article 11 of the FCTC as well as in ac-
cordance with Art. 8 of Law 18,256. The SPR thus draws upon the scientific
evidence of the FCTC and its implementation guidelines, and constitutes a
sound policy that advances important public health objectives.279
Similarly, the panel cited Article 11 of the FCTC for support of larger graphic
warnings. After the adoption of Uruguay's measures, other developing countries
followed with laws increasing the required size of warnings on tobacco packag-
ing: Namibia (55% of a cigarette pack must be covered with warning labels),
Burkina Faso (60%), Ecuador (60%), Moldova (65%), Turkey (65%), Uganda
(65%), Chad (70%), Brunei (75%), Canada (75%), and Sri Lanka (80%).280
Thailand, Pakistan, and India now require warning labels that cover 85% of the
front and back of cigarette packs.281
B. GLOBAL "ONE-HEALTH" LAW
If enterprises and foundations represent new actors and sources of global health
law, and international adjudicatory bodies represent the future of how global
health law is applied, then animals, both domesticated and wild, represent the
275. FTR Holding S.A. v. Uruguay, Request for Arbitration, ¶ 1.
276. Id.
277. Agreement on the Reciprocal Promotion and Protection of Investments (with Protocol), Switz.-
Uru., arts. 1, 5, Oct. 7, 1988, 1976 U.N.T.S. 389.
278. Philip Morris Brands Sarl v. Uruguay, ICSID Case No. ARB/10/7, Award, ¶ 391 (July 8, 2016).
279. Id. ¶ 360.
280. Id. 11 372-73.
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expansion of global health law's subjects. Human health, narrowly defined, pre-
vailed throughout most of the twentieth century. In some ways, the comprehen-
sive approaches to animal, human, and plant life should have been obvious and
inevitable from the earliest days of WHO. Its most ambitious, early eradication
effort focused on malaria.2 82 This effort made extensive use of DDT, which
"appeared to be effective everywhere, making eradication of malaria a feasible
objective. However, DDT's effectiveness against agricultural pests and house-
hold insects made prices oar, and its widespread application rapidly led to" re-
sistance in some pests.283 Beyond those effects, it also imposed significant toxic
risks on wildlife and posed serious health risks to humans as well.284 It was
banned in most developed countries during the 1970s.285
The need to widen the reach of global health law to include not only the health
of humans but also the health of the animals they raised and ate as well as the
environment in which they lived grew over the course of the 1970s. In 1972,
the U.N. held the first of many global conferences on environmental issues: the
Conference on the Human Environment in Stockholm, Sweden.286 In the decade
after the 1972 conference, scientists and nongovernmental organizations had
sounded the alarm on biodiversity losses generally and in the Amazon River basin
specifically.28 7 Logging, extraction, and agriculture explained much of the
loss.28 8 In 1987, the governing council of the United Nations Environmental
Programme created a working group to explore the possibility of developing a
legally binding treaty to protect biological resources.289 In 1991, formal multilat-
eral negotiations began for a Convention for Biological Diversity.290
The interconnectedness of habitat loss, pathogen emergence, and ecosystem
collapse led researchers, governments, and public health scholars to develop
what has been known as "one-health" approaches to animal, human, and plant
health.291 That humans, animals, and the environment are interdependent and that
their respective welfare is mutually supportive has been acknowledged for
282. Jos6 A. Najera et al., Some Lessons for the Future from the Global Malaria Eradication
Programme (1955-1969), 8 PLoS MED., Jan. 2011, at 1.
283. Id. at 2.
284. Thieu Thi Thuy, Effects of DDT on Environment and Human Health, 2 J. EDUC. & Soc. SCI.
108, 108 (2015).
285. Id.
286. Roger A. Coate, Civil Society as a Force for Peace, 9 INT'L J. PEACE STUD. 57, 59-60, 66
(2004).
287. See Daniel H. Janzen, The Future of Tropical Ecology, 17 ANN. REV. ECOLOGY & SYSTEMATICS
305, 317 (1986).
288. See Michael J. Heckenberger et al., The Legacy of Cultural Landscapes in the Brazilian
Amazon: Implications for Biodiversity, 362 PHIL. TRANSACTIONS ROYAL Soc'Y B 197, 197 (2007); Land
Use and Agriculture in the Amazon, GLOBAL FOREST ATLAS, https://globalforestatlas.yale.edu/amazon/
land-use [https://perma.cc/CT7G-3K56] (last visited Feb. 3, 2020).
289. Environment Programme Res. 14/26 (June 17, 1987).
290. International Day for Biological Diversity 22 May, U.N., https://perma.cc/GY83-H6EB (last
visited Feb. 3, 2020).
291. Advancing a 'One Health' Approach to Promote Health at the Human-Animal-Environment
Interface, supra note 171.
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centuries.292 Yet it is relatively recently that public health policies have focused
on the nexus between humans, animals (domesticated and wild), and the environ-
ment.2' After the severe acute respiratory syndrome (SARS) epidemic (which
led to the revision of the International Health Regulations) and the H5N1 avian
influenza outbreaks, one-health approaches expanded to include health-service
delivery, environmental health, and ecosystem services.29 As Dr. Robert
Breiman has explained in the context of COVID-19:
Recent studies indicate that there may be parallels between SARS and the cur-
rent pandemic. Scientists have found coronaviruses, genetically similar to the
Covidl9 virus, in pangolins, leading to a hypothesis that they served as an in-
termediate host, much like civet cats did with SARS....
We have affected these creatures in more ways than poaching them. As
human populations grow, our incursion into a variety of habitats expands even
as our appetite for certain animals remains unabated. As it has with civets,
deforestation has dramatically affected the areas available for pangolins' for-
aging, putting them in closer contact with other animals including bats, which
are reservoirs for other dangerous viruses like Nipah virus, and possibly Ebola.
This may have facilitated the spread of disease.295
This one-health strategy means establishing systems that acknowledge the
close relationship between animal and human health.2 96 These systems are ori-
ented toward areas where rapid intensification of agriculture systems, especially
with livestock keeping, have increased interactions between animals and humans,
and consequently caused significant changes in habits and practices of proximate
human communities.297
The most significant manifestation of global health law at the nexus of animals,
humans, and the environment is the Joint External Evaluation (JEE) process. The
JEE is a "voluntary, collaborative, multisectoral process" that assesses countries'
capacities to identify the most critical gaps within their human and animal health
systems, in order to prioritize opportunities for enhanced preparedness and
response.2 98 The JEE "bring[s] together national representatives from key sectors,
292. van Helden, van Helden & Hoal, supra note 17, at 497.
293. See id.
294. Nita Madhav et al., Pandemics: Risks, Impacts, and Mitigation, in 9 DISEASE CONTROL
PRIORITIES: IMPROVING HEALTH AND REDUCING POVERTY 315, 315 (Dean T. Jamison et al. eds., 3d ed.
2018).
295. Robert F. Breiman, The COVID-19 Culprit Is Us, Not Pangolins, CNN (Mar. 27, 2020, 7:42
PM), https://www.cnn.com/2020/03/27/opinions/pangolin-coronavirus-pandemic-breiman/index.html
[https://perma.cc/8JXW-TQP3].
296. See generally Justin Lessler et al., What Is a Hotspot Anyway?, 96 AM. J. TROPICAL MED.
HYGIENE 1270 (2017) (analyzing currently used definitions of "hotspot" and recommending more
specific application to animal-human interactions).
297. Lindahl & Grace, supra note 173, at 2.
298. Strengthening Health Security by Implementing the International Health Regulations, WORLD
HEALTH ORG. (2005), https://www.who.int/ihr/procedures/joint-external-evaluations/en/ [https://perma.
cc/28SY-WU2E].
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including human and animal health, agriculture, wildlife, finance, defence, secu-
rity, environment, communication, disaster management board, transportation,
customs, civil aviation, universities or institutes, and political leadership."299 The
JEE exercise identifies whether a country has adopted laws specific to the
International Health Regulations, maintains surveillance systems for animal
health, and monitors the use of antibiotics and signals for the emergence of anti-
microbial resistance.300
The JEE process itself is a function of the increasing "securitization" of global
health law. The Global Health Security Agenda (GHSA), described in more detail
in section II.C, was launched in 2014 to help build countries' capacities to address
infectious disease and other threats. The GHSA external assessment tool was
developed in collaboration with relevant international organizations with man-
dates committed to one-health approaches-WHO, FAO, and OIE-as well as
member countries. In early 2016, the WHO IHR monitoring and evaluation teams
began working with the GHSA secretariat to introduce the Joint External
Evaluation tool (JEE). The JEE tool includes the original components of the
GHSA tool but also adds in eight other key technical areas from the International
Health Regulations.
C. GLOBAL HEALTH LAW AS INTERNATIONAL PEACE AND SECURITY LAW
The formation of the GHSA coincided with the emergence of the Ebola out-
break in Guinea, Liberia, and Sierra Leone, which lasted through 2016 and
claimed over 11,000 lives. Its formation signaled the tightening relationship
between global health law and international peace and security, further inter-
twined with the U.N. Security Council's intervention into the Ebola outbreak in
September 2014. The 2014 establishment of the GHSA represents the rise of a
new kind of governance that blends the trends outlined in sections II.A and II.B.
The GHSA is a broad-based partnership comprised of approximately sixty coun-
tries who work with international organizations, foundations, and businesses.3 0 1 It
explicitly acknowledges equivalence between infectious disease and biosecurity
threats and integrates into its partnership not only WHO, FAO, and OIE but also
security-oriented international organizations like Interpol.302 According to the
GHSA, the fight against COVID-19 has been significantly enhanced by "national
plans supported by the International Health Regulations and Joint External
299. Nirmal Kandel et al., Joint External Evaluation Process: Bringing Multiple Sectors Together
for Global Health Security, 5 LANCET 857, 857 (2017).
300. See generally WHO, INTERNATIONAL HEALTH REGULATIONS (2005) COUNTRY IMPLEMENTATION
GUIDE: VOLUNTARY JOINT ExTERNAL EVALUATION (2017).
301. The U.S. Government Engagement in Global Health: A Primer, KAISER FAM. FOUND. (Feb. 5,
2019), https://www.kff.org/global-health-policy/report/the-u-s-govemment-engagement-in-global-health-
a-primer/view/print/ [https://perma.cc/646Z-54YX].
302. About the GHSA, GLOBAL HEALTH SECURITY AGENDA, https://ghsagenda.org/home/about-the-
ghsa/ [https://perma.cc/SCQ7-ZGXD] (last visited Feb. 3, 2020).
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Evaluations [which are] are guiding action and providing resources for decision
making, prioritisation, and actions."303
Although there had been global health emergencies before the International
Health Regulations were adopted and expanded in the early 2000s (for example,
pandemic influenza), they had never before been considered as proper concerns
of the world's most important authority for securing international peace and secu-
rity. With the global threat posed by both HIV/AIDS and Ebola, the U.N.
Security Council became a more regular player in the scope and applicability of
global health law. It issued recommendations, established r sponse organizations,
and played a more coordinating role between relevant U.N. agencies. In 2014, the
U.N. Security Council established the U.N. Mission for Ebola Emergency
Response (UNMEER) to meet immediate needs related to the fight against
Ebola.30 4 U.N. Security Council Resolution 1983 established that "United
Nations troops and police are part of prevention, treatment and care" in countries
battling HIV/AIDS. 3 05 Given the lack of adherence to recommendations issued
by the WHO Director-General during declared public health emergencies, one
possibility, even likelihood, is for the Security Council to implement those meas-
ures with the greater force of the U.N. Charter.306
The enhanced role of the U.N. Security Council means that global health law is
more likely to be "securitized"-that is, "the risk of international spread of infec-
tious diseases is seen not so much as a public health problem to be dealt with by
civilian authorities but a security threat to be addressed primarily by security,
military and intelligence authorities at the national and international levels"-in
the future than it has been in the past.307 Indeed, the U.N. Security Council
appears poised to intervene in the current Ebola outbreak in eastern Democratic
Republic of the Congo (DRC). On August 2, 2019, the U.N. Security Council
expressed "grave concern" about the Ebola virus outbreak in the DRC and
"stressed the urgency of broad cooperation in the response, as 'the disease could
spread rapidly, including to neighbouring countries, possibly having serious
303. Roland Driece, COVID-19 Chair's Statement: What Is the Role of GHSA2024 in This
Pandemic?, GLOBAL HEALTH SECURITY AGENDA (Mar. 17, 2020), https://ghsagenda.org/2020/03/17/
covid- 19-chairs-statement-what-is-the-role-of-ghsa2024-in-this-pandemic/ [https://perma.cc/897P-
AE4Z].
304. Pavone, supra note 212, at 323.
305. Press Release, Security Council, Unanimously Adopting 1983 (2011), Security Council
Encourages Inclusion of HIV Prevention, Treatment, Care, Support in Implementing Peacekeeping
Mandates, U.N. Press Release SC/10272 (June 7, 2011), https://www.un.org/press/en/2011/sc10272.
doc.htm [https://perma.cc/V7LB-A8XH]; S.C. Res. 1983 (June 7, 2011).
306. See Robert Frau, Combining the WHO's International Health Regulations (2005) with the UN
Security Council's Powers: Does It Make Sense for Health Governance?, in THE GOVERNANCE OF
DISEASE OUTBREAKS, supra note 212, at 327.
307. Burci, supra note 193, at 33.
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humanitarian consequences and impacting regional stability."'30 8 In other words,
the Security Council appeared ready to assume once again leadership on a specifi-
cally health-related crisis. It is now contemplating international action against
COVID-19.
The "securitization" of health carries with it significant threats to other human
rights. At the national level, measures curtailing civil liberties, like isolation and
quarantine, have long been used pretextually to detain those who may not in fact
be infectious but may be politically unpopular, like migrants.30 9 Indeed, COVID-
19-based measures have brought global migration to a grinding halt.310 At the
international level, the securitization of health may mean the stigma or isolation
of entire countries. This explains in significant part the dispute between the
United States and China at the U.N. Security Council, with the former demanding
at some points to refer to a "Wuhan" virus or a "China" virus.311
On the other hand, the intervention of the U.N. Security Council in the contexts
of HIV/AIDS and Ebola has been associated with a significant acceleration of the
mobilization of international resources and a more rapid containment of epidem-
ics once they are determined to fundamentally challenge international peace and
security. The same is hoped for COVID-19.
CONCLUSION
This Article has endeavored to identify the origins of global health law with
the major human-rights agreements that emerged in the post-World War II era,
situated, as it is, in the most significant health threat to face the world since those
institutions were formed. It has argued that global health law became increasingly
focused on the protection of infant, child, and maternal health over the course of
the 1950s and 1960s, a focus that expanded the diversity and number of subjects
308. Lindsay Mackenzie, Security Council Gravely Concerned by Ebola Outbreak in DR Congo,
Demands Immediate End to Violence Hampering Response, UN NEWS (Aug. 2, 2019), https://news.un.
org/en/story/2019/08/1043651 [https://perma.cc/EWF3-LWJV].
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EMERGING INFECTIOUs DISEASES 254, 258 (2013) ("Quarantine and other public health practices are
effective and valuable ways to control communicable disease outbreaks and public anxiety, but these
strategies have always been much debated, perceived as intrusive, and accompanied in every age and
under all political regimes by an undercurrent of suspicion, distrust, and riots. These strategic measures
have raised (and continue to raise) a variety of political, economic, social, and ethical issues (39,40). In
the face of a dramatic health crisis, individual rights have often been trampled in the name of public
good. The use of segregation or isolation to separate persons suspected of being infected has frequently
violated the liberty of outwardly healthy persons, most often from lower classes, and ethnic and
marginalized minority groups have been stigmatized and have faced discrimination. This feature, almost
inherent in quarantine, traces a line of continuity from the time of plague to the 2009 influenza A(H1N1)
pdm09 pandemic.").
310. See John Letzing, How COVID-19 Is Throttling Vital Migration Flows, WORLD ECON. F. (Apr.
8, 2020), https://www.weforum.org/agenda/2020/04/covid- 19-is-throttling-vital-migration-flows/
[https://perma.cc/N9NM-T5AG].
311. See John Bowden, China: Pompeo Has 'Sinister Motive' for Pushing 'Wuhan Virus' Language,
HILL (Mar. 26, 2020, 7:47 AM), https://thehill.com/policy/intemational/489605-china-pompeo-has-
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it targeted to include multinational enterprises. As disease threats expanded and
became increasingly understood to originate with animals, and therefore the envi-
ronment in which those animals lived, global health law also "securitized," such
that the U.N. Security Council and auxiliary security-oriented organizations
became key sources of new global health law. As a result, the future of global
health law lies in more supranational regulation of global firms, the influence of
agreements between firms, foundations, and governments (including international
organizations), and the growing body of law generated by adjudicative bodies
like international investment and trade tribunals. The result of these movements
is the future of global health law: regulation, security, and pluralism.
